WO2021085535A1 - Compound and production method therefor - Google Patents

Compound and production method therefor Download PDF

Info

Publication number
WO2021085535A1
WO2021085535A1 PCT/JP2020/040648 JP2020040648W WO2021085535A1 WO 2021085535 A1 WO2021085535 A1 WO 2021085535A1 JP 2020040648 W JP2020040648 W JP 2020040648W WO 2021085535 A1 WO2021085535 A1 WO 2021085535A1
Authority
WO
WIPO (PCT)
Prior art keywords
compound
formula
group
represented
groups
Prior art date
Application number
PCT/JP2020/040648
Other languages
French (fr)
Japanese (ja)
Inventor
正安 五十嵐
竹志 野澤
朋浩 松本
不二夫 八木橋
佐藤 一彦
Original Assignee
国立研究開発法人産業技術総合研究所
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 国立研究開発法人産業技術総合研究所 filed Critical 国立研究開発法人産業技術総合研究所
Priority to JP2021553684A priority Critical patent/JPWO2021085535A1/ja
Publication of WO2021085535A1 publication Critical patent/WO2021085535A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic System
    • C07F7/02Silicon compounds
    • C07F7/21Cyclic compounds having at least one ring containing silicon, but no carbon in the ring

Definitions

  • the present invention relates to a compound and a method for producing the same.
  • the present application claims priority based on Japanese Patent Application No. 2019-199348 filed in Japan on October 31, 2019, the contents of which are incorporated herein by reference.
  • a group of siloxane compounds having a cage-shaped skeleton which can be regarded as a condensate of orthosilicic acid or a derivative thereof, are promising in various fields as functional silicon materials. Has been done.
  • Non-Patent Document 1 it is necessary to use a large excess amount of chlorodimethylsilane ((CH 3 ) 2 HSiCl) with respect to the raw material compound (90) in order to obtain the compound (91). There was a problem that there was. This is because compound (90), which is a silicate compound, contains a large amount of hydrated water.
  • An object of the present invention is to provide a novel cage-type siloxane compound and a method for producing the same.
  • the present invention has the following general formula (2):
  • R 1 , R 2 and R 3 are alkyl groups or aryl groups which may independently have a hydrogen atom or a substituent, respectively, and are among R 1 , R 2 and R 3. When two or more are the alkyl or aryl groups, these groups may be bonded to each other to form a ring; X is a halogen atom.
  • Z 1 is a group represented by hydrogen atom or formula "-SiR 1 R 2 R 3" may be the same or different from each other (2p 1 +6) number of Z 1, provided that , one or more Z 1, the general formula is a group represented by "-SiR 1 R 2 R 3"; p 1, R 1, R 2 and R 3 are the same as above .)
  • a method for producing a compound for obtaining the compound represented by is provided.
  • Z 10 is a hydrogen atom or a group represented by the general formula "-SiR 10 R 20 R 30 ", and (2p 1 + 6) Z 10s. May be the same or different from each other, except that one or more Z 10s are groups represented by the general formula "-SiR 10 R 20 R 30 "; R 10 , R 20 and R.
  • Reference numeral 30 denotes an alkyl group or an aryl group which may independently have a hydrogen atom or a substituent, and two or more of R 10 , R 20 and R 30 are the alkyl group or the aryl group.
  • the R 10 , R 20 and R 30 are independently hydrogen atoms, alkyl groups having 1 to 20 carbon atoms or aryls having 6 to 20 carbon atoms. It may be a group.
  • the R 10 , R 20 and R 30 are independently hydrogen atoms, alkyl groups having 1 to 6 carbon atoms or aryls having 6 to 12 carbon atoms, respectively. It may be a group.
  • the present invention has the following general formula (1021):
  • Z 11 is a hydrogen atom or a group represented by the general formula "-SiR 11 R 21 R 31 ", and eight Z 11s may be the same or different from each other, but one or one.
  • R 11 , R 21 and R 31 are the alkyl groups or aryl groups of the above alkyl groups or aryl groups having 6 to 12 carbon atoms, these groups are bonded to each other to form a ring.
  • the Z 11 is a group represented by the formula "-Si (CH 3) 3", and one of Z 11 is a hydrogen atom compound, 6 Z 11 is the formula "-Si (CH 3) 3 a group represented by "and two Z 11 compound is a hydrogen atom, a group five Z 11 represented by the formula" -Si (CH 3) 3 ', 3 Z 11 is a hydrogen atom, except for compounds).
  • a novel cage-type siloxane compound and a method for producing the same are provided.
  • R 1 , R 2 and R 3 are alkyl groups or aryl groups which may independently have a hydrogen atom or a substituent, respectively, and are among R 1 , R 2 and R 3. When two or more are the alkyl or aryl groups, these groups may be bonded to each other to form a ring; X is a halogen atom.
  • Z 1 is a group represented by hydrogen atom or formula "-SiR 1 R 2 R 3" may be the same or different from each other (2p 1 +6) number of Z 1, provided that , one or more Z 1, the general formula is a group represented by "-SiR 1 R 2 R 3"; p 1, R 1, R 2 and R 3 are the same as above .
  • This is a method for producing a compound (1), which obtains a compound represented by (in the present specification, may be referred to as "compound (1)").
  • a cage-type siloxane compound can be produced by a practical method without using a large excess amount of the raw material compound.
  • the target compound (1) will be described.
  • Compound (1) is represented by the general formula (1).
  • p 1 is to define the size of the cage of the compound (1) is 0, 1 or 2. That is, the compound (1) when p 1 is 0 is represented by the following general formula (11) (in the present specification, this compound may be referred to as “compound (11)”), and p 1
  • the compound (1) when is 1 is represented by the following general formula (12) (in the present specification, this compound may be referred to as “compound (12)”), and p 1 is 2.
  • the compound (1) in the case is represented by the following general formula (13) (in the present specification, this compound may be referred to as "compound (13)").
  • Z 1 is a hydrogen atom (-H) or a group represented by the general formula "-SiR 1 R 2 R 3".
  • R 1 , R 2 and R 3 are each independently an alkyl group or an aryl group which may have a hydrogen atom or a substituent.
  • the alkyl group in R 1 , R 2 and R 3 may be linear, branched or cyclic.
  • the number of carbon atoms of the linear or branched alkyl group in R 1 , R 2 and R 3 is not particularly limited, but is preferably 1 to 20.
  • Examples of such a linear or branched alkyl group include a methyl group, an ethyl group, an n-propyl group, an isopropyl group, an n-butyl group, an isobutyl group, a sec-butyl group, and a tert-butyl group.
  • n-pentyl group isopentyl group, neopentyl group, tert-pentyl group, 1-methylbutyl group, n-hexyl group, 2-methylpentyl group, 3-methylpentyl group, 2,2-dimethylbutyl group, 2,3- Dimethylbutyl group, n-heptyl group, 2-methylhexyl group, 3-methylhexyl group, 2,2-dimethylpentyl group, 2,3-dimethylpentyl group, 2,4-dimethylpentyl group, 3,3-dimethyl Pentyl group, 3-ethylpentyl group, 2,2,3-trimethylbutyl group, n-octyl group, isooctyl group, nonyl group, decyl group, undecyl group, dodecyl group, tridecyl group, tetradecyl group, pentadecyl group, hexadec
  • the cyclic alkyl group in R 1 , R 2 and R 3 may be monocyclic or polycyclic.
  • the number of carbon atoms of the cyclic alkyl group is not particularly limited as long as it is 3 or more, but it is preferably 3 to 20.
  • Examples of the cyclic alkyl group include a cyclopropyl group, a cyclobutyl group, a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, a cyclooctyl group, a cyclononyl group, a cyclodecyl group, a norbornyl group, an isobornyl group, a 1-adamantyl group and a 2-.
  • the cyclic alkyl group preferably has 3 to 15 carbon atoms, and may be, for example, any of 3 to 10 and 3 to 6, or 5 to 15 and 5 to 10. There may be.
  • the alkyl group in R 1 , R 2 and R 3 may be a mixture of a linear or branched chain structure and a cyclic structure.
  • Examples of the alkyl group in which such a chain structure and a cyclic structure are mixed include the above-mentioned linear or branched chain such as a cyclopentylmethyl group, a 1-cyclopentylethyl group, a cyclohexylmethyl group, and a 1-cyclohexylethyl group.
  • Examples thereof include a group having a structure in which one or more hydrogen atoms in the above-mentioned cyclic alkyl group are substituted with the above-mentioned linear or branched alkyl group.
  • the number of carbon atoms of the alkyl group in which the chain structure and the cyclic structure are mixed is not particularly limited as long as it is 4 or more, but is preferably 4 to 25, and may be, for example, 6 to 15.
  • the aryl group in R 1 , R 2 and R 3 may be monocyclic or polycyclic.
  • the aryl group preferably has 6 to 20 carbon atoms, and examples of the aryl group include a phenyl group, a 1-naphthyl group, a 2-naphthyl group, an o-tolyl group, an m-tolyl group, and p-. tolyl group, xylyl group (dimethylphenyl group) can be mentioned, further, one or more hydrogen atoms of these aryl groups, the aryl group, or is substituted with the alkyl group in R 1 ⁇ R 3 A group having a similar structure is also mentioned.
  • the aryl group having these substituents preferably has 6 to 20 carbon atoms.
  • the aryl group preferably has 6 to 12 carbon atoms.
  • the alkyl group and aryl group in R 1 , R 2 and R 3 may have a substituent.
  • the fact that an alkyl group and an aryl group have a substituent is one or one of these groups. It means that two or more hydrogen atoms are substituted with a group other than the hydrogen atom.
  • the term "group" includes not only an atomic group formed by bonding a plurality of atoms but also one atom, unless otherwise specified.
  • Examples of the substituent in R 1 , R 2 and R 3 include halogen atoms such as chlorine atom, bromine atom and iodine atom; hydroxyl group; carboxy group; one methylene group (-CH 2- ), or two.
  • Substituted alkyl groups, aryl groups and the like can be mentioned.
  • alkyl group in "a methylene group, an oxygen atom, a carbonyl group, or an alkyl group substituted oxycarbonyl group" for example, the same ones as the alkyl group in R 1, R 2 and R 3 Can be mentioned.
  • alkyl group in which the methylene group is substituted with an oxygen atom, a carbonyloxy group, or an oxycarbonyl group the position of substitution of the methylene group by the substituent (oxygen atom, carbonyloxy group, or oxycarbonyl group) is
  • the number of substituents is not particularly limited and may be 1 or 2 or more. Further, when the number of substituents is 2 or more, these substituents may be the same as each other or may be different from each other.
  • R 1 , R 2 and R 3 are independently hydrogen atoms, alkyl groups having 1 to 20 carbon atoms (linear or branched alkyl groups having 1 to 20 carbon atoms, cyclic groups having 3 to 20 carbon atoms, respectively). Alkyl group) or an aryl group having 6 to 20 carbon atoms, each independently having a hydrogen atom and an alkyl group having 1 to 6 carbon atoms (a linear or branched alkyl having 1 to 6 carbon atoms). A group, a cyclic alkyl group having 3 to 6 carbon atoms) or an aryl group having 6 to 12 carbon atoms is more preferable. In such R 1 , R 2 and R 3 , the alkyl group or aryl group may have a substituent.
  • the ring formed by bonding two or more of R 1 , R 2 and R 3 to each other is a silicon-containing aliphatic ring or silicon-containing ring containing a silicon atom as an atom forming a ring skeleton. It is an aromatic ring.
  • the bonding position of R 1 , R 2 or R 3 when forming the ring is not particularly limited.
  • the bond position may be a carbon atom at the end of the chain structure or a non-terminal carbon atom.
  • the alkyl group or aryl group has the substituent, the substituent does not serve as the bond position when forming a ring.
  • the number of binding sites of R 1 , R 2 or R 3 when forming the ring may be 1 or 2 or more. That is, the ring may be either monocyclic or polycyclic.
  • Z 1 may be the same or different from each other. That, (2p 1 +6) number of Z 1 may all be the same, may be different, all may be the same part only.
  • Z 1 is a hydrogen atom
  • one or more Z 1 is a group represented by the general formula "-SiR 1 R 2 R 3"
  • the may be a group represented by (2p 1 +6) number of Z 1 are all the general formula "-SiR 1 R 2 R 3".
  • a trialkylsilyl group for example, a trialkylsilyl group, a dialkylsilyl group, a monoalkylsilyl group, a triarylsilyl group, a diarylsilyl group, a mono Examples thereof include an arylsilyl group, a dialkyl monoarylsilyl group, a monoalkyldiarylsilyl group, a monoalkyl monoarylsilyl group, and a silyl group (-SiH 3 ).
  • Compound (2) is represented by the general formula (2).
  • P 1 in the general formula (2) is the same as p 1 in the general formula (1).
  • Compound (2) can be produced, for example, by the method described in International Publication No. 2018/193732.
  • a compound that does not contain hydrated water can be prepared by appropriately selecting the operation (for example, washing conditions, removal conditions, purification conditions, etc.) at the time of its production.
  • the operation for example, washing conditions, removal conditions, purification conditions, etc.
  • a compound (2) for example, a crystal
  • Compound (2) may not contain a molecule of a solvent component, or may contain a molecule of a solvent component other than water.
  • the solvent component include N, N-dimethylacetamide (DMAc) and the like.
  • DMAc N, N-dimethylacetamide
  • the compound (2) containing a molecule of DMAc is an example of a preferable compound (2) which is easy to produce and does not contain hydrated water.
  • the number of molecules of the solvent component contained in one molecule of the compound (2) can be adjusted according to the operating conditions at the time of producing the compound (2).
  • the number of molecules of DMAc contained in one molecule of the compound (2) may be, for example, any one of 1 to 20, but this is an example.
  • Compound (3) is represented by the general formula (3).
  • the monovalent group having the structure in which X in the compound (3) is removed is the same as the group represented by the general formula “ ⁇ SiR 1 R 2 R 3 ” in Z 1 in the compound (1). ..
  • R 1 in the general formula (3), R 2 and R 3 are the same as R 1, R 2 and R 3 in the general formula (1).
  • X is a halogen atom.
  • the halogen atom include a chlorine atom, a bromine atom, an iodine atom and the like.
  • the compound (3) when X is a chlorine atom more specifically, for example, trialkylsilyl chloride, dialkylsilyl chloride, monoalkylsilyl chloride, triarylsilyl chloride, diarylsilyl chloride, monoarylsilyl.
  • examples thereof include chloride, dialkyl monoarylsilyl chloride, monoalkyldiarylsilyl chloride, monoalkyl monoarylsilyl chloride and the like.
  • Compound (1) is obtained by reacting compound (2) with compound (3).
  • the compound (3) to be subjected to the reaction may be only one kind or two or more kinds, and may be appropriately selected depending on the structure of the target compound (1). When two or more compounds (3) are used, their combinations and ratios can be appropriately adjusted according to the intended purpose.
  • the amount of compound (3) used can be appropriately adjusted according to the structure of the target compound (1) and the like.
  • the amount of compound (3) used can be adjusted according to the number of groups represented by the general formula "-SiR 1 R 2 R 3" in the target compound (1).
  • the amount of the compound (3) is, when the relative amount of the compound (2) is 1 to 2 times molar quantity, the formula in one molecule " A compound (1) having 1 to 2 groups represented by " -SiR 1 R 2 R 3" is preferably obtained.
  • the amount of the compound (3) is, relative to the amount of the compound (2), when it is 3 to 4 times the molar amount of the general formula in a molecule " A compound (1) having 3 to 4 groups represented by " -SiR 1 R 2 R 3" is preferably obtained.
  • the amount of the compound (3) is, relative to the amount of the compound (2), when it is 5-6 times the molar amount of the general formula in a molecule "
  • a compound (1) having 5 to 6 groups represented by " -SiR 1 R 2 R 3" is preferably obtained.
  • the general formula "-" in one molecule The compound (1) having 6 groups represented by " SiR 1 R 2 R 3" can be obtained in a higher yield. In this case, for example, when the amount of the compound (3) used is 10 times the molar amount or less, the excessive use of the compound (3) is suppressed.
  • the general amount in one molecule when p 1 is 1 or 2, and the amount of compound (3) used is 7 to 8 times the molar amount of compound (2) used, the general amount in one molecule.
  • a compound (1) having 7 to 8 groups represented by the formula “ ⁇ SiR 1 R 2 R 3” is preferably obtained.
  • the general formula "-" in one molecule when p 1 is 1, and the amount of compound (3) used is 8 times the molar amount or more of the amount of compound (2) used, the general formula "-" in one molecule.
  • the compound (1) having 8 groups represented by " SiR 1 R 2 R 3" can be obtained in a higher yield.
  • the amount of the compound (3) used is preferably 17 times the molar amount or less, more preferably 12 times the molar amount or less, the overuse of the compound (3) is suppressed.
  • the amount of compound (3) used is 9 to 10 times the molar amount of compound (2) used
  • the above general formula "in one molecule" A compound (1) having 9 to 10 groups represented by " -SiR 1 R 2 R 3" is preferably obtained.
  • the amount of compound (3) used is 10 times the molar amount or more of the amount of compound (2) used, the general formula "-" in one molecule.
  • the compound (1) having 10 groups represented by " SiR 1 R 2 R 3" can be obtained in a higher yield. In this case, for example, when the amount of the compound (3) used is 14 times the molar amount or less, the excessive use of the compound (3) is suppressed.
  • the amount of the compound (3) used so far is an example for efficiently obtaining the target compound (1) in a good yield, and the amount of the compound (3) used is the compound (3). It can be adjusted as appropriate in consideration of the overall manufacturing conditions of 1). In addition, the amount of the compound (3) used so far means the total amount of all kinds of the compound (3) used when two or more kinds of the compound (3) are used.
  • the base is preferably an organic base.
  • organic base include aromatic amines such as aniline, pyridine and piperidine; and aliphatic amines such as triethylamine and diisopropylethylamine.
  • one type of base may be used alone, two or more types may be used in combination, and when two or more types are used in combination, the combination and ratio thereof may be appropriately adjusted according to the purpose. Can be adjusted.
  • the amount of the base used can be adjusted, for example, according to the amount of the compound (3) used.
  • the amount of the base used is preferably 1 to 2 times the molar amount of the compound (3), and may be, for example, 1 to 1.5 times the molar amount.
  • the amount of the base used is 1 times the molar amount or more, the amount of the compound (1) produced is further increased.
  • the amount of the base used is twice the molar amount or less, the excessive use of the base is suppressed.
  • the reaction between the compound (2) and the compound (3) may be carried out without using a solvent, but it is preferably carried out using a solvent.
  • the solvent By using the solvent, the fluidity of the reaction solution is improved, the reaction between the compound (2) and the compound (3) proceeds more smoothly, and the amount of by-products produced can be reduced.
  • the solvent is preferably one that does not have reactivity with the components used in the reaction, such as compound (2) and compound (3).
  • the solvent include ethers (compounds having an ether bond) such as tetrahydrofuran (THF), 1,4-dioxane, tetrahydropyran, dibutyl ether, 1,2-dimethoxyethane; N, N-dimethylformamide (DMF).
  • N, N-Dimethylacetamide (DMAc) and other amides Ethyl acetate, butyl acetate and other esters; 1,2-Dichloroethane, methylene chloride, chlorobenzene and other halogenated hydrocarbons (hydrocarbons having a halogen atom as a substituent) Nitriles such as propionitrile and acetonitrile (compounds having a cyano group); hydrocarbons such as toluene, n-hexane and methylcyclohexane can be mentioned.
  • DMAc N, N-Dimethylacetamide
  • Ethyl acetate, butyl acetate and other esters 1,2-Dichloroethane, methylene chloride, chlorobenzene and other halogenated hydrocarbons (hydrocarbons having a halogen atom as a substituent)
  • Nitriles such as propionitrile and acetonitrile (compounds having
  • one type of the solvent may be used alone, two or more types may be used in combination, and when two or more types are used in combination, the combination and ratio thereof may be appropriately adjusted according to the purpose. Can be adjusted.
  • the amount of the solvent used is not particularly limited, but for example, it is preferably 0 to 100 ml, more preferably 10 to 50 ml, with respect to 1 mmol of the compound (2) used.
  • the amount of the solvent used is 10 ml or more, the effect of using the solvent can be obtained more remarkably.
  • the amount of the solvent used is 100 ml or less, the excessive use of the solvent is suppressed.
  • one type of the other component may be used alone, two or more types may be used in combination, and when two or more types are used in combination, the combination and ratio thereof shall be determined. It can be adjusted as appropriate according to the purpose.
  • the amount of the other component used is not particularly limited and can be arbitrarily selected according to the type of the other component.
  • the reaction temperature at the time of the reaction between the compound (2) and the compound (3) may be appropriately adjusted and is not particularly limited.
  • the reaction temperature is preferably 10 to 40 ° C, and may be room temperature such as 18 to 30 ° C.
  • the reaction time during the reaction between the compound (2) and the compound (3) may be appropriately adjusted according to other conditions such as the reaction temperature so that the amount of the compound (1) produced is increased, and is not particularly limited. ..
  • the reaction time is, for example, preferably 1 to 72 hours, more preferably 1 to 60 hours.
  • compound (1) can be taken out by a known method.
  • post-treatment operations such as filtration, washing, extraction, pH adjustment, dehydration, and concentration are performed individually or in combination of two or more, as needed, and then concentration, crystallization, and so on.
  • Compound (1) can be extracted by reprecipitation, column chromatography, or the like. Further, the extracted compound (1) can be further subjected to operations such as crystallization, reprecipitation, column chromatography, extraction, and stirring and washing of crystals with a solvent, either alone or in combination of two or more, if necessary. It may be purified by performing it once or twice or more.
  • post-treatment is carried out by a known method as necessary, and then the compound (1) is not taken out. Other steps may be performed.
  • the desired compound (1) can be obtained. Even if a plurality of types of the compound (1) are produced, its characteristics can be inferred from the structure of the compound (1). Therefore, by selecting a post-treatment operation or a purification operation suitable for the characteristics, the target compound ( The yield of 1) can be improved. Further, the yield of the compound (1) can be improved by improving the production rate of the target compound (1) by adjusting the amount of the compound (3) used, other reaction conditions and the like. ..
  • the structure of compound (1) is, for example, nuclear magnetic resonance (NMR) spectroscopy, mass spectrometry (MS), infrared spectroscopy (IR), ultraviolet / visible spectroscopy (UV-VIS absorption spectrum), elemental analysis. It can be confirmed by a known method such as.
  • NMR nuclear magnetic resonance
  • MS mass spectrometry
  • IR infrared spectroscopy
  • UV-VIS absorption spectrum ultraviolet / visible spectroscopy
  • Z 10 is a hydrogen atom or a group represented by the general formula "-SiR 10 R 20 R 30 ", and (2p 1 + 6) Z 10s. May be the same or different from each other, except that one or more Z 10s are groups represented by the general formula "-SiR 10 R 20 R 30 "; R 10 , R 20 and R.
  • Reference numeral 30 denotes an alkyl group or an aryl group which may independently have a hydrogen atom or a substituent, and two or more of R 10 , R 20 and R 30 are the alkyl group or the aryl group.
  • these groups may be bonded to each other to form a ring.
  • p 1 is 1, and all eight Z 10s are represented by the formula "-Si (CH 3 ) 3 ", the formula “-Si (CH 3 ) 2 H”, and the formula "-Si ((((CH 3) 3) 3".
  • compound (10) can be used as a functional silicon material and is highly useful.
  • p 1 is to define the size of the cage of the compound (10), is 0, 1 or 2.
  • the p 1 in the general formula (10) is the same as the p 1 in the general formula (1) described above.
  • Compound (10) has a compound (10) in which p 1 is 1 and all eight Z 10s are groups represented by the formula “-Si (CH 3 ) 3 ”, and compound (10) has p 1 in 1 and eight.
  • Z 10 in the general formula (10) is "when p 1 is 1, all eight Z 10s are not groups represented by the formula" -Si (CH 3 ) 3 "", "p. When 1 is 1, all 8 Z 10s are not groups represented by the formula "-Si (CH 3 ) 2 H”"," 8 Z when p 1 is 1.
  • All 10 are not groups represented by the formula "-Si ((4-CH 3 ) C 6 H 4 ) (CH 3 ) 2 " (dimethyl (4-methylphenyl) silyl group) "," p 1 is When 1, all eight Z 10s are groups represented by the formula “-Si ((4-CBr 3 ) C 6 H 4 ) (CH 3 ) 2 " (4-tribromomethylphenyl (dimethyl)). It does not become a silyl group) ",” When p 1 is 1, all eight Z 10s are represented by the formula "-Si ((4-COOH) C 6 H 4 ) (CH 3 ) 2 ".
  • all eight Z 10s are not groups represented by the formula "-Si (CH 3 ) 2 CH 2 Cl”"
  • p 1 When p 1 is 1, eight Z 10s are All are not groups represented by the formula "-Si (CH 3 ) 2 (OSi (CH 3 ) 3 )""
  • p 1 When p 1 is 1, seven Z 10s are the formula" -Si ( CH 3 ) It is a group represented by " 3 ", and one Z 10 is not a hydrogen atom.
  • Z 10s are of the formula "-Si.” (CH 3 ) 3 "is a group represented by” and two Z 10s are not hydrogen atoms ", and" when p 1 is 1, five Z 10s are of the formula " -Si (CH 3 ) 3 "is a group represented by”, and three Z 10s are not hydrogen atoms ", except that the general formula described above is satisfied. It is the same as Z 1 in (1).
  • Z 10s may be the same or different from each other, except that one or two or more Z 10s are described in the general formula “ ⁇ SiR 10 R 20”. It is a group represented by "R 30".
  • R 10 , R 20 and R 30 in the general formula (10) are the same as R 1 , R 2 and R 3 in the general formula (1) described above, respectively.
  • R 10 , R 20 and R 30 are the above-mentioned alkyl group or aryl group, these groups (alkyl group or aryl group) are bonded to these groups.
  • a ring may be formed together with the silicon atom (Si).
  • R 10 , R 20 and R 30 are independently hydrogen atoms and alkyl groups having 1 to 20 carbon atoms (linear or branched chains having 1 to 20 carbon atoms). Alkyl groups (cyclic alkyl groups having 3 to 20 carbon atoms) or aryl groups having 6 to 20 carbon atoms can be mentioned. In R 10 , R 20 and R 30 of such compound (10), the alkyl group or aryl group may have a substituent.
  • R 10 , R 20 and R 30 are independently hydrogen atoms and alkyl groups having 1 to 6 carbon atoms (linear or branched chains having 1 to 6 carbon atoms, respectively). , A cyclic alkyl group having 3 to 6 carbon atoms) or an aryl group having 6 to 12 carbon atoms.
  • the alkyl group or aryl group may have a substituent.
  • Z 11 is a hydrogen atom or a group represented by the general formula "-SiR 11 R 21 R 31 ", and the six Z 11s may be the same or different from each other, but one or one.
  • the two or more Z 11, formula "-SiR 11 R 21 R 31" in be a group represented by; R 11, R 21 and R 31 are independently a hydrogen atom, 6
  • R 11 , R 21 and R 31 are the alkyl groups or aryl groups of the above alkyl groups or aryl groups having 6 to 12 carbon atoms, these groups are bonded to each other to form a ring. It may be formed.
  • Examples thereof include compounds represented by.
  • R 11 , R 21 and R 31 in the general formula (1011) are first described except that the alkyl group and the aryl group each have a limited number of carbon atoms and do not have a substituent. It is the same as R 1 , R 2 and R 3 in the general formula (1) described.
  • R 11 , R 21 and R 31 are the above-mentioned alkyl group or aryl group, these groups (alkyl group or aryl group) are bonded to these groups.
  • a ring may be formed together with the silicon atom (Si).
  • Z 11 in the general formula (1011) has the above-described general formula (1) except that the alkyl group and the aryl group each have a limited number of carbon atoms and each has no substituent. ) Is the same as Z 1 in.
  • Z 11 are the same as described above, may be the same or different from each other 8 Z 11, provided that one or more of Z 11, the formula "-SiR 11 R It is a group represented by " 21 R 31".
  • the Z 11 is a group represented by the formula "-Si (CH 3) 3", and one of Z 11 is a hydrogen atom compound, 6 Z 11 is the formula "-Si (CH 3) 3 a group represented by "and two Z 11 compound is a hydrogen atom, a group five Z 11 represented by the formula" -Si (CH 3) 3 ', 3 Z ( Excluding compounds in which 11 is a hydrogen atom).
  • Z 11 is the same as above, 10 Z 11 may be the same or different, provided that one or more of Z 11, the formula "-SiR 11 R It is a group represented by " 21 R 31".) Examples thereof include compounds represented by.
  • Examples of the preferred compound (10) are the same as those of the preferred compound (1) listed above (however, in the general formula (10), p 1 is 1 and all eight Z 10s are of the formula "-”.
  • p 1 is 1, five Z 10s are groups represented by the formula "-Si (CH 3 ) 3 ", and three Z 10s are hydrogen atoms. (Except for compounds that are used).
  • Compound (10) can be produced by the method for producing a compound according to an embodiment of the present invention, which has been described above.
  • Example 1 Compound (22) -1, which is a mixed crystal containing DMAc, was used as compound (2), and compound (1021) -1 was produced as compound (1). More specifically, it is as follows. Compound (22) -1 (311 mg, 0.20 mmol) was dissolved in THF (6 ml), and aniline (176 mg, 2.4 mmol) and phenyldihydrochlorosilane (285 mg, 2.0 mmol) were added to the obtained solution. , Stirred at room temperature for 2 hours to obtain a suspended solution.
  • Example 2 Compound (22) -2, which is a mixed crystal containing DMAc, was used as compound (2), and compound (1021) -2 was produced as compound (1). More specifically, it is as follows. Compound (22) -2 (106 mg, 0.10 mmol) was dissolved in THF (3 ml), and aniline (78.5 mg, 0.84 mmol) and chlorodimethylsilane (79.6 mg, 0.84 mmol) were added to the obtained solution. ) was added, and the mixture was stirred at room temperature for 90 minutes to obtain a suspended solution. From various NMR spectra of this suspension solution, it was confirmed that compound (1021) -2 ("Si 8 O 12 [OSiMe 2 H] 8 ”) was produced.
  • Example 3 Compound (22) -3, which is a mixed crystal containing DMAc, was used as compound (2), and compound (1021) -3 and compound (1021) -4 were produced as compound (1). More specifically, it is as follows. Aniline (140 mg, 1.5 mmol) and THF (2 ml) were mixed to prepare an aniline solution having a concentration of 0.70 mmol / ml. Separately, chlorotrimethylsilane (163 mg, 1.5 mmol) and THF (2 ml) were mixed to prepare a chlorotrimethylsilane solution having a concentration of 0.68 mmol / ml.
  • reaction solution was further added with the above-mentioned aniline solution (14 ⁇ l, 0.9 mg as aniline, 0.01 mmol) and the above-mentioned chlorotrimethylsilane solution (16 ⁇ l, chlorotrimethylsilane).
  • aniline solution 14 ⁇ l, 0.9 mg as aniline, 0.01 mmol
  • chlorotrimethylsilane solution 16 ⁇ l, chlorotrimethylsilane.
  • a mixture of compound (1021) -3 and compound (1021) -4 was obtained by adding 1.1 mg (0.01 mmol) and reacting at room temperature for another 23 hours.
  • the NMR data of the obtained compounds (1021) -3 and compound (1021) -4 are shown below.
  • Example 4 Compound (22) -3, which is a mixed crystal containing DMAc, was used as compound (2), and compound (1021) -5 was produced as compound (1). More specifically, it is as follows. Compound (22) -3 (1.55 g, 1.00 mmol) was dissolved in THF (30 ml), and aniline (724 mg, 9.90 mmol) and n-butylchlorodimethylsilane (1.49 g, 9.90 mmol) was added and the mixture was stirred at room temperature for 3 hours to obtain a suspended solution.
  • the present invention can be used as a functional silicon material or an intermediate thereof, and further as a method for producing these.

Abstract

A method for producing a compound represented by general formula (1) by reacting a compound represented by general formula (2) (wherein p1 is 0, 1, or 2) with a compound represented by general formula (3) (wherein R1, R2, and R3 are each independently a hydrogen atom, an alkyl group, or an aryl group and in the case where two or all of the R1, R2, and R3 are each the alkyl or aryl group, these groups may be bonded to each other to form a ring; and X is a halogen atom). (In general formula (1), Z1 is a hydrogen atom or a group represented by the general formula -SiR1R2R3, and the (2p1+6) Z1 moieties may be the same or different but one or more of the Z1 moieties are each the group of the general formula -SiR1R2R3; and p1, R1, R2, and R3 are the same as defined above.)

Description

化合物及びその製造方法Compounds and methods for producing them
 本発明は、化合物及びその製造方法に関する。
 本願は、2019年10月31日に日本に出願された特願2019-199348号に基づき優先権を主張し、その内容をここに援用する。
The present invention relates to a compound and a method for producing the same.
The present application claims priority based on Japanese Patent Application No. 2019-199348 filed in Japan on October 31, 2019, the contents of which are incorporated herein by reference.
 オルトケイ酸の縮合物又はその誘導体と見做せる、かご型の骨格を有する一群のシロキサン化合物は、機能性ケイ素材料として種々の分野で有望であり、新規化合物の探索と、その製造方法が種々検討されている。 A group of siloxane compounds having a cage-shaped skeleton, which can be regarded as a condensate of orthosilicic acid or a derivative thereof, are promising in various fields as functional silicon materials. Has been done.
 例えば、このようなかご型シロキサン化合物の1種として、以下に示す合成ルートによって、下記式(90)で表される化合物(本明細書においては、「化合物(90)」と称することがある)を原料として、下記式(91)で表される化合物(本明細書においては、「化合物(91)」と称することがある)を得たことが開示されている(非特許文献1参照)。 For example, as one of such cage-type siloxane compounds, a compound represented by the following formula (90) by the synthetic route shown below (in this specification, it may be referred to as "compound (90)"). It is disclosed that a compound represented by the following formula (91) (in this specification, it may be referred to as “compound (91)”) was obtained using the above as a raw material (see Non-Patent Document 1).
Figure JPOXMLDOC01-appb-C000006
Figure JPOXMLDOC01-appb-C000006
 しかし、非特許文献1に記載の方法では、化合物(91)を得るために、原料である化合物(90)に対して、クロロジメチルシラン((CHHSiCl)を大過剰量使用する必要があるという問題点があった。これは、シリケート化合物である化合物(90)が、大量の水和水を含んでいるためである。 However, in the method described in Non-Patent Document 1, it is necessary to use a large excess amount of chlorodimethylsilane ((CH 3 ) 2 HSiCl) with respect to the raw material compound (90) in order to obtain the compound (91). There was a problem that there was. This is because compound (90), which is a silicate compound, contains a large amount of hydrated water.
 このように、従来のかご型シロキサン化合物には、実用的な方法では製造できないものがあり、製造方法の改良が望まれていた。
 また、現状、かご型シロキサン化合物の探索も十分に為されているとは言えず、新規のかご型シロキサン化合物の探索も望まれていた。
As described above, some conventional cage-type siloxane compounds cannot be produced by a practical method, and improvement of the production method has been desired.
Further, at present, it cannot be said that the search for a cage-type siloxane compound has been sufficiently performed, and the search for a new cage-type siloxane compound has also been desired.
 本発明は、新規のかご型シロキサン化合物と、その製造方法を提供することを課題とする。 An object of the present invention is to provide a novel cage-type siloxane compound and a method for producing the same.
 本発明は、下記一般式(2): The present invention has the following general formula (2):
Figure JPOXMLDOC01-appb-C000007
 (式中、pは0、1又は2である。)
で表される化合物と、下記一般式(3):
Figure JPOXMLDOC01-appb-C000007
(In the formula, p 1 is 0, 1 or 2.)
The compound represented by and the following general formula (3):
Figure JPOXMLDOC01-appb-C000008
 (式中、R、R及びRは、それぞれ独立に、水素原子、又は置換基を有していてもよいアルキル基若しくはアリール基であり、R、R及びRのうちの2個以上が前記アルキル基又はアリール基である場合、これら基は相互に結合して環を形成していてもよく;Xはハロゲン原子である。)
で表される化合物と、を反応させることにより、下記一般式(1):
Figure JPOXMLDOC01-appb-C000008
(In the formula, R 1 , R 2 and R 3 are alkyl groups or aryl groups which may independently have a hydrogen atom or a substituent, respectively, and are among R 1 , R 2 and R 3. When two or more are the alkyl or aryl groups, these groups may be bonded to each other to form a ring; X is a halogen atom.)
By reacting with the compound represented by, the following general formula (1):
Figure JPOXMLDOC01-appb-C000009
 (式中、Zは、水素原子又は一般式「-SiR」で表される基であり、(2p+6)個のZは互いに同一でも異なっていてもよく、ただし、1個又は2個以上のZは、前記一般式「-SiR」で表される基であり;p、R、R及びRは、上記と同じである。)
で表される化合物を得る、化合物の製造方法を提供する。
Figure JPOXMLDOC01-appb-C000009
(Wherein, Z 1 is a group represented by hydrogen atom or formula "-SiR 1 R 2 R 3" may be the same or different from each other (2p 1 +6) number of Z 1, provided that , one or more Z 1, the general formula is a group represented by "-SiR 1 R 2 R 3"; p 1, R 1, R 2 and R 3 are the same as above .)
Provided is a method for producing a compound for obtaining the compound represented by.
 また、本発明は、下記一般式(10): Further, the present invention has the following general formula (10):
Figure JPOXMLDOC01-appb-C000010
 (式中、pは0、1又は2であり;Z10は、水素原子又は一般式「-SiR102030」で表される基であり、(2p+6)個のZ10は互いに同一でも異なっていてもよく、ただし、1個又は2個以上のZ10は、前記一般式「-SiR102030」で表される基であり;R10、R20及びR30は、それぞれ独立に、水素原子、又は置換基を有していてもよいアルキル基若しくはアリール基であり、R10、R20及びR30のうちの2個以上が前記アルキル基又はアリール基である場合、これら基は相互に結合して環を形成していてもよい。)
で表される化合物(ただし、pが1であり、8個のZ10がすべて式「-Si(CH」、式「-Si(CHH」、式「-Si((4-CH)C)(CH」、式「-Si((4-CBr)C)(CH」、式「-Si((4-COOH)C)(CH」、式「-Si(CH(OSi(CH)」、式「-Si(CH(CH=CH)」、式「-Si(CH=CH」、式「-Si(CHCHCl」、又は式「-Si(CH(OSi(CH)」で表される基である化合物と、pが1であり、7個のZ10が式「-Si(CH」で表される基であり、1個のZ10が水素原子である化合物と、pが1であり、6個のZ10が式「-Si(CH」で表される基であり、2個のZ10が水素原子である化合物と、pが1であり、5個のZ10が式「-Si(CH」で表される基であり、3個のZ10が水素原子である化合物と、を除く)を提供する。
Figure JPOXMLDOC01-appb-C000010
(In the formula, p 1 is 0, 1 or 2; Z 10 is a hydrogen atom or a group represented by the general formula "-SiR 10 R 20 R 30 ", and (2p 1 + 6) Z 10s. May be the same or different from each other, except that one or more Z 10s are groups represented by the general formula "-SiR 10 R 20 R 30 "; R 10 , R 20 and R. Reference numeral 30 denotes an alkyl group or an aryl group which may independently have a hydrogen atom or a substituent, and two or more of R 10 , R 20 and R 30 are the alkyl group or the aryl group. In some cases, these groups may be bonded to each other to form a ring.)
Compounds represented by (where p 1 is 1 and all eight Z 10s are of the formula "-Si (CH 3 ) 3 ", of the formula "-Si (CH 3 ) 2 H", of the formula "-Si ( (4-CH 3 ) C 6 H 4 ) (CH 3 ) 2 ", formula" -Si ((4-CBr 3 ) C 6 H 4 ) (CH 3 ) 2 ", formula" -Si ((4-COOH) ) C 6 H 4 ) (CH 3 ) 2 ”, formula“ -Si (CH 3 ) 2 (OSi (CH 3 ) 3 ) ”, formula“ -Si (CH 3 ) 2 (CH = CH 2 ) ”, formula A group represented by "-Si (CH = CH 2 ) 3 ", the formula "-Si (CH 3 ) 2 CH 2 Cl", or the formula "-Si (CH 3 ) 2 (OSi (CH 3 ) 3 )". A compound in which p 1 is 1, seven Z 10s are groups represented by the formula "-Si (CH 3 ) 3 ", and one Z 10 is a hydrogen atom, and p. 1 is 1, 6 Z 10s are groups represented by the formula "-Si (CH 3 ) 3 ", 2 Z 10s are hydrogen atoms, and p 1 is 1. (Excluding compounds in which 5 Z 10s are groups represented by the formula "-Si (CH 3 ) 3 " and 3 Z 10s are hydrogen atoms).
 本発明の一般式(10)で表される化合物においては、前記R10、R20及びR30が、それぞれ独立に、水素原子、炭素数1~20のアルキル基又は炭素数6~20のアリール基であってもよい。
 本発明の一般式(10)で表される化合物においては、前記R10、R20及びR30が、それぞれ独立に、水素原子、炭素数1~6のアルキル基又は炭素数6~12のアリール基であってもよい。
 また、本発明は、下記一般式(1021):
In the compound represented by the general formula (10) of the present invention, the R 10 , R 20 and R 30 are independently hydrogen atoms, alkyl groups having 1 to 20 carbon atoms or aryls having 6 to 20 carbon atoms. It may be a group.
In the compound represented by the general formula (10) of the present invention, the R 10 , R 20 and R 30 are independently hydrogen atoms, alkyl groups having 1 to 6 carbon atoms or aryls having 6 to 12 carbon atoms, respectively. It may be a group.
Further, the present invention has the following general formula (1021):
Figure JPOXMLDOC01-appb-C000011
 (式中、Z11は、水素原子又は一般式「-SiR112131」で表される基であり、8個のZ11は互いに同一でも異なっていてもよく、ただし、1個又は2個以上のZ11は、前記一般式「-SiR112131」で表される基であり;R11、R21及びR31は、それぞれ独立に、水素原子、炭素数1~6のアルキル基又は炭素数6~12のアリール基であり、R11、R21及びR31のうちの2個以上が前記アルキル基又はアリール基である場合、これら基は相互に結合して環を形成していてもよい。)
で表される化合物(ただし、8個のZ11がすべて式「-Si(CH」、式「-Si(CHH」、式「-Si((4-CH)C)(CH」、式「-Si((4-CBr)C)(CH」、式「-Si((4-COOH)C)(CH」、式「-Si(CH(OSi(CH)」、式「-Si(CH(CH=CH)」、式「-Si(CH=CH」、式「-Si(CHCHCl」、又は式「-Si(CH(OSi(CH)」で表される基である化合物と、7個のZ11が式「-Si(CH」で表される基であり、1個のZ11が水素原子である化合物と、6個のZ11が式「-Si(CH」で表される基であり、2個のZ11が水素原子である化合物と、5個のZ11が式「-Si(CH」で表される基であり、3個のZ11が水素原子である化合物と、を除く)を提供する。
Figure JPOXMLDOC01-appb-C000011
(In the formula, Z 11 is a hydrogen atom or a group represented by the general formula "-SiR 11 R 21 R 31 ", and eight Z 11s may be the same or different from each other, but one or one. the two or more Z 11, formula "-SiR 11 R 21 R 31" in be a group represented by; R 11, R 21 and R 31 are independently a hydrogen atom, 6 When two or more of R 11 , R 21 and R 31 are the alkyl groups or aryl groups of the above alkyl groups or aryl groups having 6 to 12 carbon atoms, these groups are bonded to each other to form a ring. It may be formed.)
Compound represented by (where eight Z 11 are all expressions "-Si (CH 3) 3", the formula "-Si (CH 3) 2 H", the formula "-Si ((4-CH 3) C 6 H 4 ) (CH 3 ) 2 ”, formula“ -Si ((4-CBr 3 ) C 6 H 4 ) (CH 3 ) 2 ”, formula“ -Si ((4-COOH) C 6 H 4 ) ( CH 3 ) 2 ”, formula“ -Si (CH 3 ) 2 (OSi (CH 3 ) 3 ) ”, formula“ -Si (CH 3 ) 2 (CH = CH 2 ) ”, formula“ -Si (CH = CH) 2 ) 3 ", the compound which is the group represented by the formula" -Si (CH 3 ) 2 CH 2 Cl ", or the formula" -Si (CH 3 ) 2 (OSi (CH 3 ) 3) ", and 7 pieces. the Z 11 is a group represented by the formula "-Si (CH 3) 3", and one of Z 11 is a hydrogen atom compound, 6 Z 11 is the formula "-Si (CH 3) 3 a group represented by "and two Z 11 compound is a hydrogen atom, a group five Z 11 represented by the formula" -Si (CH 3) 3 ', 3 Z 11 is a hydrogen atom, except for compounds).
 本発明によれば、新規のかご型シロキサン化合物と、その製造方法が提供される。 According to the present invention, a novel cage-type siloxane compound and a method for producing the same are provided.
<<化合物の製造方法>>
 本発明の一実施形態に係る化合物の製造方法は、下記一般式(2):
<< Compound manufacturing method >>
A method for producing a compound according to an embodiment of the present invention is described in the following general formula (2):
Figure JPOXMLDOC01-appb-C000012
 (式中、pは0、1又は2である。)
で表される化合物(本明細書においては、「化合物(2)」と称することがある)と、下記一般式(3):
Figure JPOXMLDOC01-appb-C000012
(In the formula, p 1 is 0, 1 or 2.)
(In the present specification, it may be referred to as "Compound (2)") and the following general formula (3):
Figure JPOXMLDOC01-appb-C000013
 (式中、R、R及びRは、それぞれ独立に、水素原子、又は置換基を有していてもよいアルキル基若しくはアリール基であり、R、R及びRのうちの2個以上が前記アルキル基又はアリール基である場合、これら基は相互に結合して環を形成していてもよく;Xはハロゲン原子である。)
で表される化合物(本明細書においては、「化合物(3)」と称することがある)と、を反応させることにより、下記一般式(1):
Figure JPOXMLDOC01-appb-C000013
(In the formula, R 1 , R 2 and R 3 are alkyl groups or aryl groups which may independently have a hydrogen atom or a substituent, respectively, and are among R 1 , R 2 and R 3. When two or more are the alkyl or aryl groups, these groups may be bonded to each other to form a ring; X is a halogen atom.)
By reacting with a compound represented by (in the present specification, it may be referred to as "compound (3)"), the following general formula (1):
Figure JPOXMLDOC01-appb-C000014
 (式中、Zは、水素原子又は一般式「-SiR」で表される基であり、(2p+6)個のZは互いに同一でも異なっていてもよく、ただし、1個又は2個以上のZは、前記一般式「-SiR」で表される基であり;p、R、R及びRは、上記と同じである。)
で表される化合物(本明細書においては、「化合物(1)」と称することがある)を得る、化合物(1)の製造方法である。
Figure JPOXMLDOC01-appb-C000014
(Wherein, Z 1 is a group represented by hydrogen atom or formula "-SiR 1 R 2 R 3" may be the same or different from each other (2p 1 +6) number of Z 1, provided that , one or more Z 1, the general formula is a group represented by "-SiR 1 R 2 R 3"; p 1, R 1, R 2 and R 3 are the same as above .)
This is a method for producing a compound (1), which obtains a compound represented by (in the present specification, may be referred to as "compound (1)").
 本実施形態の製造方法によれば、従来の化合物(91)の製造方法等とは異なり、原料化合物を大過剰量使用することなく、実用的な方法で、かご型シロキサン化合物を製造できる。
 以下、まず、目的物である化合物(1)について説明する。
According to the production method of the present embodiment, unlike the conventional method for producing the compound (91), a cage-type siloxane compound can be produced by a practical method without using a large excess amount of the raw material compound.
Hereinafter, first, the target compound (1) will be described.
<化合物(1)>
 化合物(1)は、前記一般式(1)で表される。
 一般式(1)中、pは、化合物(1)のかごのサイズを規定しており、0、1又は2である。
 すなわち、pが0である場合の化合物(1)は、下記一般式(11)で表され(本明細書においては、この化合物を「化合物(11)」と称することがある)、pが1である場合の化合物(1)は、下記一般式(12)で表され(本明細書においては、この化合物を「化合物(12)」と称することがある)、pが2である場合の化合物(1)は、下記一般式(13)で表される(本明細書においては、この化合物を「化合物(13)」と称することがある)。
<Compound (1)>
Compound (1) is represented by the general formula (1).
In the general formula (1), p 1 is to define the size of the cage of the compound (1) is 0, 1 or 2.
That is, the compound (1) when p 1 is 0 is represented by the following general formula (11) (in the present specification, this compound may be referred to as “compound (11)”), and p 1 The compound (1) when is 1 is represented by the following general formula (12) (in the present specification, this compound may be referred to as “compound (12)”), and p 1 is 2. The compound (1) in the case is represented by the following general formula (13) (in the present specification, this compound may be referred to as "compound (13)").
Figure JPOXMLDOC01-appb-C000015
 (式中、Zは、上記と同じである。)
Figure JPOXMLDOC01-appb-C000015
(In the formula, Z 1 is the same as above.)
 すなわち、pが0である場合の化合物(1)(化合物(11))の製造方法は、下記式(21): That is, the method for producing the compound (1) (compound (11)) when p 1 is 0 is described in the following formula (21):
Figure JPOXMLDOC01-appb-C000016
で表される化合物と、下記一般式(3):
Figure JPOXMLDOC01-appb-C000016
The compound represented by and the following general formula (3):
Figure JPOXMLDOC01-appb-C000017
 (式中、R、R、R及びXは、上記と同じである。)
で表される化合物(化合物(3))と、を反応させることにより、下記一般式(11):
Figure JPOXMLDOC01-appb-C000017
(In the formula, R 1 , R 2 , R 3 and X are the same as above.)
By reacting with the compound represented by (compound (3)), the following general formula (11):
Figure JPOXMLDOC01-appb-C000018
 (式中、Zは、上記と同じである。)
で表される化合物(化合物(11))を得る、化合物(11)の製造方法である。
Figure JPOXMLDOC01-appb-C000018
(In the formula, Z 1 is the same as above.)
This is a method for producing the compound (11), which obtains the compound represented by (compound (11)).
 また、pが1である場合の化合物(1)(化合物(12))の製造方法は、下記式(22): The method for producing the compound (1) (compound (12)) when p 1 is 1 is described in the following formula (22):
Figure JPOXMLDOC01-appb-C000019
で表される化合物(2,4,6,8,10,12,14,16,17,18,19,20-ドデカオキサ1,3,5,7,9,11,13,15-オクタシラペンタシクロ[9.5.1.13,9.15,15.17,13.]イコサン1,3,5,7,9,11,13,15-オクタノール(CAS番号119558-12-2)、本明細書においては、「化合物(22)」と称することがある)と、下記一般式(3):
Figure JPOXMLDOC01-appb-C000019
Compounds represented by (2,4,6,8,10,12,14,16,17,18,19,20-dodecaoxa 1,3,5,7,9,11,13,15-octacilapenta cyclo [9.5.1.1 3,9 .1 5,15 .1 7,13. ] icosane 1,3,5,7,9,11,13,15- octanol (CAS No. 119558-12-2 ), In the present specification, it may be referred to as “compound (22)”) and the following general formula (3):
Figure JPOXMLDOC01-appb-C000020
 (式中、R、R、R及びXは、上記と同じである。)
で表される化合物(化合物(3))と、を反応させることにより、下記一般式(12):
Figure JPOXMLDOC01-appb-C000020
(In the formula, R 1 , R 2 , R 3 and X are the same as above.)
By reacting with the compound represented by (compound (3)), the following general formula (12):
Figure JPOXMLDOC01-appb-C000021
 (式中、Zは、上記と同じである。)
で表される化合物(化合物(12))を得る、化合物(12)の製造方法である。
Figure JPOXMLDOC01-appb-C000021
(In the formula, Z 1 is the same as above.)
This is a method for producing the compound (12), which obtains the compound represented by (compound (12)).
 また、pが2である場合の化合物(1)(化合物(13))の製造方法は、下記式(23): Further, the method for producing the compound (1) (compound (13)) when p 1 is 2 is described in the following formula (23):
Figure JPOXMLDOC01-appb-C000022
で表される化合物と、下記一般式(3):
Figure JPOXMLDOC01-appb-C000022
The compound represented by and the following general formula (3):
Figure JPOXMLDOC01-appb-C000023
 (式中、R、R、R及びXは、上記と同じである。)
で表される化合物(化合物(3))と、を反応させることにより、下記一般式(13):
Figure JPOXMLDOC01-appb-C000023
(In the formula, R 1 , R 2 , R 3 and X are the same as above.)
By reacting with the compound represented by (compound (3)), the following general formula (13):
Figure JPOXMLDOC01-appb-C000024
 (式中、Zは、上記と同じである。)
で表される化合物(化合物(13))を得る、化合物(13)の製造方法である。
Figure JPOXMLDOC01-appb-C000024
(In the formula, Z 1 is the same as above.)
This is a method for producing the compound (13), which obtains the compound represented by (compound (13)).
 一般式(1)中、Zは、水素原子(-H)又は一般式「-SiR」で表される基である。そして、R、R及びRは、それぞれ独立に、水素原子、又は置換基を有していてもよいアルキル基若しくはアリール基である。 In the general formula (1), Z 1 is a hydrogen atom (-H) or a group represented by the general formula "-SiR 1 R 2 R 3". And R 1 , R 2 and R 3 are each independently an alkyl group or an aryl group which may have a hydrogen atom or a substituent.
 R、R及びRにおける前記アルキル基は、直鎖状、分岐鎖状及び環状のいずれであってもよい。 The alkyl group in R 1 , R 2 and R 3 may be linear, branched or cyclic.
 R、R及びRにおける、直鎖状又は分岐鎖状の前記アルキル基の炭素数は、特に限定されないが、1~20であることが好ましい。
 このような直鎖状又は分岐鎖状のアルキル基としては、例えば、メチル基、エチル基、n-プロピル基、イソプロピル基、n-ブチル基、イソブチル基、sec-ブチル基、tert-ブチル基、n-ペンチル基、イソペンチル基、ネオペンチル基、tert-ペンチル基、1-メチルブチル基、n-ヘキシル基、2-メチルペンチル基、3-メチルペンチル基、2,2-ジメチルブチル基、2,3-ジメチルブチル基、n-ヘプチル基、2-メチルヘキシル基、3-メチルヘキシル基、2,2-ジメチルペンチル基、2,3-ジメチルペンチル基、2,4-ジメチルペンチル基、3,3-ジメチルペンチル基、3-エチルペンチル基、2,2,3-トリメチルブチル基、n-オクチル基、イソオクチル基、ノニル基、デシル基、ウンデシル基、ドデシル基、トリデシル基、テトラデシル基、ペンタデシル基、ヘキサデシル基、ヘプタデシル基、オクタデシル基、ノナデシル基、イコシル基等が挙げられる。
 直鎖状又は分岐鎖状のアルキル基の炭素数は、1~10であることがより好ましく、例えば、1~6、及び1~3のいずれかであってもよい。
The number of carbon atoms of the linear or branched alkyl group in R 1 , R 2 and R 3 is not particularly limited, but is preferably 1 to 20.
Examples of such a linear or branched alkyl group include a methyl group, an ethyl group, an n-propyl group, an isopropyl group, an n-butyl group, an isobutyl group, a sec-butyl group, and a tert-butyl group. n-pentyl group, isopentyl group, neopentyl group, tert-pentyl group, 1-methylbutyl group, n-hexyl group, 2-methylpentyl group, 3-methylpentyl group, 2,2-dimethylbutyl group, 2,3- Dimethylbutyl group, n-heptyl group, 2-methylhexyl group, 3-methylhexyl group, 2,2-dimethylpentyl group, 2,3-dimethylpentyl group, 2,4-dimethylpentyl group, 3,3-dimethyl Pentyl group, 3-ethylpentyl group, 2,2,3-trimethylbutyl group, n-octyl group, isooctyl group, nonyl group, decyl group, undecyl group, dodecyl group, tridecyl group, tetradecyl group, pentadecyl group, hexadecyl group , Heptadecyl group, octadecyl group, nonadecil group, icosyl group and the like.
The linear or branched alkyl group preferably has 1 to 10 carbon atoms, and may be, for example, any of 1 to 6 and 1 to 3.
 R、R及びRにおける、環状の前記アルキル基は、単環状及び多環状のいずれであってもよい。
 環状の前記アルキル基の炭素数は、3以上であれば特に限定されないが、3~20であることが好ましい。
 環状の前記アルキル基としては、例えば、シクロプロピル基、シクロブチル基、シクロペンチル基、シクロヘキシル基、シクロヘプチル基、シクロオクチル基、シクロノニル基、シクロデシル基、ノルボルニル基、イソボルニル基、1-アダマンチル基、2-アダマンチル基、トリシクロデシル基等が挙げられる。
 環状のアルキル基の炭素数は、3~15であることがより好ましく、例えば、3~10、及び3~6のいずれかであってもよいし、5~15及び5~10のいずれかであってもよい。
The cyclic alkyl group in R 1 , R 2 and R 3 may be monocyclic or polycyclic.
The number of carbon atoms of the cyclic alkyl group is not particularly limited as long as it is 3 or more, but it is preferably 3 to 20.
Examples of the cyclic alkyl group include a cyclopropyl group, a cyclobutyl group, a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, a cyclooctyl group, a cyclononyl group, a cyclodecyl group, a norbornyl group, an isobornyl group, a 1-adamantyl group and a 2-. Examples thereof include an adamantyl group and a tricyclodecyl group.
The cyclic alkyl group preferably has 3 to 15 carbon atoms, and may be, for example, any of 3 to 10 and 3 to 6, or 5 to 15 and 5 to 10. There may be.
 R、R及びRにおける前記アルキル基は、直鎖状又は分岐鎖状の鎖状構造と、環状構造と、が混在したものであってもよい。
 このような鎖状構造と環状構造が混在した前記アルキル基としては、例えば、シクロペンチルメチル基、1-シクロペンチルエチル基、シクロヘキシルメチル基、1-シクロヘキシルエチル基等の、上述の直鎖状又は分岐鎖状のアルキル基における1個又は2個以上の水素原子が、上述の環状のアルキル基で置換された構造を有する基;メチルシクロペンチル基、エチルシクロペンチル基、メチルシクロヘキシル基、エチルシクロヘキシル基、ジメチルシクロヘキシル基等の、上述の環状のアルキル基における1個又は2個以上の水素原子が、上述の直鎖状又は分岐鎖状のアルキル基で置換された構造を有する基等が挙げられる。
 鎖状構造と環状構造が混在した前記アルキル基の炭素数は、4以上であれば特に限定されないが、4~25であることが好ましく、例えば、6~15であってもよい。
The alkyl group in R 1 , R 2 and R 3 may be a mixture of a linear or branched chain structure and a cyclic structure.
Examples of the alkyl group in which such a chain structure and a cyclic structure are mixed include the above-mentioned linear or branched chain such as a cyclopentylmethyl group, a 1-cyclopentylethyl group, a cyclohexylmethyl group, and a 1-cyclohexylethyl group. A group having a structure in which one or more hydrogen atoms in the alkyl group in the form are substituted with the above-mentioned cyclic alkyl group; methylcyclopentyl group, ethylcyclopentyl group, methylcyclohexyl group, ethylcyclohexyl group, dimethylcyclohexyl group. Examples thereof include a group having a structure in which one or more hydrogen atoms in the above-mentioned cyclic alkyl group are substituted with the above-mentioned linear or branched alkyl group.
The number of carbon atoms of the alkyl group in which the chain structure and the cyclic structure are mixed is not particularly limited as long as it is 4 or more, but is preferably 4 to 25, and may be, for example, 6 to 15.
 R、R及びRにおける前記アリール基(aryl group)は、単環状及び多環状のいずれであってもよい。 The aryl group in R 1 , R 2 and R 3 may be monocyclic or polycyclic.
 前記アリール基の炭素数は、6~20であることが好ましく、前記アリール基としては、例えば、フェニル基、1-ナフチル基、2-ナフチル基、o-トリル基、m-トリル基、p-トリル基、キシリル基(ジメチルフェニル基)等が挙げられ、さらに、これらアリール基の1個又は2個以上の水素原子が、前記アリール基、又は、R~Rにおける前記アルキル基で置換された構造を有する基も挙げられる。これら置換基を有するアリール基の炭素数は、6~20であることが好ましい。
 アリール基の炭素数は、6~12であることがより好ましい。
The aryl group preferably has 6 to 20 carbon atoms, and examples of the aryl group include a phenyl group, a 1-naphthyl group, a 2-naphthyl group, an o-tolyl group, an m-tolyl group, and p-. tolyl group, xylyl group (dimethylphenyl group) can be mentioned, further, one or more hydrogen atoms of these aryl groups, the aryl group, or is substituted with the alkyl group in R 1 ~ R 3 A group having a similar structure is also mentioned. The aryl group having these substituents preferably has 6 to 20 carbon atoms.
The aryl group preferably has 6 to 12 carbon atoms.
 R、R及びRにおける、前記アルキル基並びにアリール基は、置換基を有していてもよい。
 本明細書においては、R、R及びRの場合に限らず、アルキル基及びアリール基が置換基を有するとは、特に断りのない限り、これらの基を構成している1個又は2個以上の水素原子が、水素原子以外の基で置換されていることを意味する。そして、本明細書において、「基」とは、特に断りのない限り、複数個の原子が結合してなる原子団だけでなく、1個の原子も包含するものとする。
The alkyl group and aryl group in R 1 , R 2 and R 3 may have a substituent.
In the present specification, not only in the case of R 1 , R 2 and R 3 , but unless otherwise specified, the fact that an alkyl group and an aryl group have a substituent is one or one of these groups. It means that two or more hydrogen atoms are substituted with a group other than the hydrogen atom. In the present specification, the term "group" includes not only an atomic group formed by bonding a plurality of atoms but also one atom, unless otherwise specified.
 R、R及びRにおける前記置換基としては、例えば、塩素原子、臭素原子、ヨウ素原子等のハロゲン原子;水酸基;カルボキシ基;1個のメチレン基(-CH-)、又は2個以上の互いに隣接していないメチレン基が、酸素原子(-O-)、カルボニルオキシ基(-C(=O)-O-)、又はオキシカルボニル基(-O-C(=O)-)で置換されたアルキル基及びアリール基等が挙げられる。 Examples of the substituent in R 1 , R 2 and R 3 include halogen atoms such as chlorine atom, bromine atom and iodine atom; hydroxyl group; carboxy group; one methylene group (-CH 2- ), or two. The above non-adjacent methylene groups are oxygen atoms (-O-), carbonyloxy groups (-C (= O) -O-), or oxycarbonyl groups (-OC (= O)-). Substituted alkyl groups, aryl groups and the like can be mentioned.
 上述の「メチレン基が、酸素原子、カルボニルオキシ基、又はオキシカルボニル基で置換されたアルキル基」におけるアルキル基としては、例えば、R、R及びRにおける前記アルキル基と同様のものが挙げられる。 Above The alkyl group in "a methylene group, an oxygen atom, a carbonyl group, or an alkyl group substituted oxycarbonyl group", for example, the same ones as the alkyl group in R 1, R 2 and R 3 Can be mentioned.
 上述の「メチレン基が、酸素原子、カルボニルオキシ基、又はオキシカルボニル基で置換されたアルキル基」において、置換基(酸素原子、カルボニルオキシ基、又はオキシカルボニル基)によるメチレン基の置換位置は、特に限定されず、置換基の数は、1であってもよいし、2以上であってもよい。また、置換基の数が2以上である場合、これら置換基は、互いに同一であってもよいし、異なっていてもよい。 In the above-mentioned "alkyl group in which the methylene group is substituted with an oxygen atom, a carbonyloxy group, or an oxycarbonyl group", the position of substitution of the methylene group by the substituent (oxygen atom, carbonyloxy group, or oxycarbonyl group) is The number of substituents is not particularly limited and may be 1 or 2 or more. Further, when the number of substituents is 2 or more, these substituents may be the same as each other or may be different from each other.
 R、R及びRは、それぞれ独立に、水素原子、炭素数1~20のアルキル基(炭素数1~20の直鎖状又は分岐鎖状のアルキル基、炭素数3~20の環状のアルキル基)又は炭素数6~20のアリール基であることが好ましく、それぞれ独立に、水素原子、炭素数1~6のアルキル基(炭素数1~6の直鎖状又は分岐鎖状のアルキル基、炭素数3~6の環状のアルキル基)又は炭素数6~12のアリール基であることがより好ましい。このようなR、R及びRにおいては、いずれも、前記アルキル基又はアリール基が置換基を有していてもよい。 R 1 , R 2 and R 3 are independently hydrogen atoms, alkyl groups having 1 to 20 carbon atoms (linear or branched alkyl groups having 1 to 20 carbon atoms, cyclic groups having 3 to 20 carbon atoms, respectively). Alkyl group) or an aryl group having 6 to 20 carbon atoms, each independently having a hydrogen atom and an alkyl group having 1 to 6 carbon atoms (a linear or branched alkyl having 1 to 6 carbon atoms). A group, a cyclic alkyl group having 3 to 6 carbon atoms) or an aryl group having 6 to 12 carbon atoms is more preferable. In such R 1 , R 2 and R 3 , the alkyl group or aryl group may have a substituent.
 一般式「-SiR」で表される基において、R、R及びRのうちの2個以上(2個又は3個)が前記アルキル基又はアリール基である場合、これら基(アルキル基又はアリール基)は相互に結合して、これら基が結合しているケイ素原子(Si)とともに環を形成していてもよい。 In the group represented by the general formula "-SiR 1 R 2 R 3 ", when two or more (two or three) of R 1 , R 2 and R 3 are the alkyl group or the aryl group. These groups (alkyl groups or aryl groups) may be bonded to each other to form a ring together with the silicon atom (Si) to which these groups are bonded.
 R、R及びRのうちの2個以上が相互に結合して形成している前記環は、環骨格を形成している原子としてケイ素原子を含む、含ケイ素脂肪族環又は含ケイ素芳香族環である。
 前記環を形成している場合の、R、R又はRの結合位置は、特に限定されない。例えば、R、R又はRが鎖状構造を有する場合には、前記結合位置は、前記鎖状構造の末端の炭素原子であってもよいし、非末端の炭素原子であってもよい。ただし、前記アルキル基又はアリール基が前記置換基を有する場合には、前記置換基は、環を形成する場合の前記結合位置とはならない。
 前記環を形成している場合の、R、R又はRの結合部位の数は、1であってもよいし、2以上であってもよい。すなわち、前記環は、単環状及び多環状のいずれであってもよい。
The ring formed by bonding two or more of R 1 , R 2 and R 3 to each other is a silicon-containing aliphatic ring or silicon-containing ring containing a silicon atom as an atom forming a ring skeleton. It is an aromatic ring.
The bonding position of R 1 , R 2 or R 3 when forming the ring is not particularly limited. For example, when R 1 , R 2 or R 3 has a chain structure, the bond position may be a carbon atom at the end of the chain structure or a non-terminal carbon atom. Good. However, when the alkyl group or aryl group has the substituent, the substituent does not serve as the bond position when forming a ring.
The number of binding sites of R 1 , R 2 or R 3 when forming the ring may be 1 or 2 or more. That is, the ring may be either monocyclic or polycyclic.
 一般式(1)中、(2p+6)個(すなわち、pが0の場合には6個、pが1の場合には8個、pが2の場合には10個)のZは、互いに同一でも異なっていてもよい。すなわち、(2p+6)個のZは、すべて同一であってもよいし、すべて異なっていてもよいし、一部のみ同一であってもよい。 In the general formula (1), (2p 1 + 6) (that is, 6 when p 1 is 0, 8 when p 1 is 1, and 10 when p 1 is 2). Z 1 may be the same or different from each other. That, (2p 1 +6) number of Z 1 may all be the same, may be different, all may be the same part only.
 ただし、一般式(1)中、すべてのZが水素原子であることはなく、1個又は2個以上のZは、前記一般式「-SiR」で表される基であり、(2p+6)個のZがすべて、前記一般式「-SiR」で表される基であってもよい。 However, in the general formula (1) is not that all of Z 1 is a hydrogen atom, one or more Z 1 is a group represented by the general formula "-SiR 1 R 2 R 3" , and the may be a group represented by (2p 1 +6) number of Z 1 are all the general formula "-SiR 1 R 2 R 3".
 一般式(1)中、1個又は2個以上のZが水素原子である場合(すなわち、化合物(1)が、すべてのZが前記一般式「-SiR」で表される基であるもの、ではない場合)、前記一般式「-SiR」で表される基の結合位置は、特に限定されない。 Table In the general formula (1), if one or more Z 1 is a hydrogen atom (i.e., Compound (1), all of Z 1 is the general formula "-SiR 1 R 2 R 3" The bonding position of the group represented by the general formula "-SiR 1 R 2 R 3" is not particularly limited.
 一般式「-SiR」で表される基として、より具体的には、例えば、トリアルキルシリル基、ジアルキルシリル基、モノアルキルシリル基、トリアリールシリル基、ジアリールシリル基、モノアリールシリル基、ジアルキルモノアリールシリル基、モノアルキルジアリールシリル基、モノアルキルモノアリールシリル基、シリル基(-SiH)等が挙げられる。 More specifically, as the group represented by the general formula "-SiR 1 R 2 R 3 ", for example, a trialkylsilyl group, a dialkylsilyl group, a monoalkylsilyl group, a triarylsilyl group, a diarylsilyl group, a mono Examples thereof include an arylsilyl group, a dialkyl monoarylsilyl group, a monoalkyldiarylsilyl group, a monoalkyl monoarylsilyl group, and a silyl group (-SiH 3 ).
 好ましい化合物(1)の例を以下に列挙する。ただし、化合物(1)はこれらに限定されない。 Examples of the preferred compound (1) are listed below. However, compound (1) is not limited to these.
Figure JPOXMLDOC01-appb-C000025
Figure JPOXMLDOC01-appb-C000025
Figure JPOXMLDOC01-appb-C000026
Figure JPOXMLDOC01-appb-C000026
Figure JPOXMLDOC01-appb-C000027
Figure JPOXMLDOC01-appb-C000027
Figure JPOXMLDOC01-appb-C000028
Figure JPOXMLDOC01-appb-C000028
Figure JPOXMLDOC01-appb-C000029
Figure JPOXMLDOC01-appb-C000029
Figure JPOXMLDOC01-appb-C000030
Figure JPOXMLDOC01-appb-C000030
Figure JPOXMLDOC01-appb-C000031
Figure JPOXMLDOC01-appb-C000031
Figure JPOXMLDOC01-appb-C000032
Figure JPOXMLDOC01-appb-C000032
Figure JPOXMLDOC01-appb-C000033
Figure JPOXMLDOC01-appb-C000033
Figure JPOXMLDOC01-appb-C000034
Figure JPOXMLDOC01-appb-C000034
Figure JPOXMLDOC01-appb-C000035
Figure JPOXMLDOC01-appb-C000035
Figure JPOXMLDOC01-appb-C000036
Figure JPOXMLDOC01-appb-C000036
Figure JPOXMLDOC01-appb-C000037
Figure JPOXMLDOC01-appb-C000037
Figure JPOXMLDOC01-appb-C000038
Figure JPOXMLDOC01-appb-C000038
Figure JPOXMLDOC01-appb-C000039
Figure JPOXMLDOC01-appb-C000039
Figure JPOXMLDOC01-appb-C000040
Figure JPOXMLDOC01-appb-C000040
Figure JPOXMLDOC01-appb-C000041
Figure JPOXMLDOC01-appb-C000041
Figure JPOXMLDOC01-appb-C000042
Figure JPOXMLDOC01-appb-C000042
Figure JPOXMLDOC01-appb-C000043
Figure JPOXMLDOC01-appb-C000043
Figure JPOXMLDOC01-appb-C000044
Figure JPOXMLDOC01-appb-C000044
Figure JPOXMLDOC01-appb-C000045
Figure JPOXMLDOC01-appb-C000045
Figure JPOXMLDOC01-appb-C000046
Figure JPOXMLDOC01-appb-C000046
Figure JPOXMLDOC01-appb-C000047
Figure JPOXMLDOC01-appb-C000047
Figure JPOXMLDOC01-appb-C000048
Figure JPOXMLDOC01-appb-C000048
Figure JPOXMLDOC01-appb-C000049
Figure JPOXMLDOC01-appb-C000049
Figure JPOXMLDOC01-appb-C000050
Figure JPOXMLDOC01-appb-C000050
Figure JPOXMLDOC01-appb-C000051
Figure JPOXMLDOC01-appb-C000051
 好ましい化合物(1)の他の例としては、ここまでに列挙した化合物(1)中のアルキル基又はアリール基において、1個又は2個以上の水素原子が先に説明した置換基で置換されているものも挙げられる。 As another example of the preferred compound (1), in the alkyl group or aryl group in the compound (1) listed so far, one or two or more hydrogen atoms are substituted with the substituent described above. Some are also listed.
 次に、原料である化合物(2)及び化合物(3)について、順次説明する。 Next, the raw materials, compound (2) and compound (3), will be described in order.
<化合物(2)>
 化合物(2)は、前記一般式(2)で表される。
 一般式(2)中のpは、一般式(1)中のpと同じである。
<Compound (2)>
Compound (2) is represented by the general formula (2).
P 1 in the general formula (2) is the same as p 1 in the general formula (1).
 化合物(2)は、例えば、国際公開第2018/193732号に記載の方法で製造できる。 Compound (2) can be produced, for example, by the method described in International Publication No. 2018/193732.
 化合物(2)としては、その製造時における操作(例えば、洗浄条件、取り出し条件、精製条件等)を適宜選択することで、水和水を含まないものを調製できる。このような、水和水を含まない化合物(2)(例えば結晶)を用いることで、化合物(3)等の、化合物(1)の製造原料を大過剰量使用することが避けられ、化合物(1)を効率よく、良好な収率で製造できる。 As the compound (2), a compound that does not contain hydrated water can be prepared by appropriately selecting the operation (for example, washing conditions, removal conditions, purification conditions, etc.) at the time of its production. By using such a compound (2) (for example, a crystal) that does not contain hydrated water, it is possible to avoid using a large excess amount of the raw material for producing the compound (1) such as the compound (3), and the compound (for example). 1) can be produced efficiently and in a good yield.
 化合物(2)は、溶媒成分の分子を含まないものであってもよいし、水以外の溶媒成分の分子を含むものであってもよい。前記溶媒成分としては、例えば、N,N-ジメチルアセトアミド(DMAc)等が挙げられる。DMAcの分子を含む化合物(2)は、製造が容易で、かつ水和水を含まない化合物(2)として、好ましいものの一例である。 Compound (2) may not contain a molecule of a solvent component, or may contain a molecule of a solvent component other than water. Examples of the solvent component include N, N-dimethylacetamide (DMAc) and the like. The compound (2) containing a molecule of DMAc is an example of a preferable compound (2) which is easy to produce and does not contain hydrated water.
 1分子の化合物(2)が含む溶媒成分の分子数は、化合物(2)の製造時における操作条件によって、調節できる。
 例えば、DMAcの分子を含む化合物(2)において、1分子の化合物(2)が含むDMAcの分子数は、例えば、1~20のいずれかであってもよいが、これは一例である。
The number of molecules of the solvent component contained in one molecule of the compound (2) can be adjusted according to the operating conditions at the time of producing the compound (2).
For example, in the compound (2) containing a molecule of DMAc, the number of molecules of DMAc contained in one molecule of the compound (2) may be, for example, any one of 1 to 20, but this is an example.
<化合物(3)>
 化合物(3)は、前記一般式(3)で表される。
 化合物(3)中のXが取り除かれた構造を有する1価の基は、化合物(1)中のZにおける、一般式「-SiR」で表される基と同じである。
<Compound (3)>
Compound (3) is represented by the general formula (3).
The monovalent group having the structure in which X in the compound (3) is removed is the same as the group represented by the general formula “−SiR 1 R 2 R 3 ” in Z 1 in the compound (1). ..
 一般式(3)中のR、R及びRは、一般式(1)中のR、R及びRと同じである。 R 1 in the general formula (3), R 2 and R 3 are the same as R 1, R 2 and R 3 in the general formula (1).
 一般式(3)中、Xはハロゲン原子である。
 前記ハロゲン原子としては、例えば、塩素原子、臭素原子、ヨウ素原子等が挙げられる。
In the general formula (3), X is a halogen atom.
Examples of the halogen atom include a chlorine atom, a bromine atom, an iodine atom and the like.
 例えば、Xが塩素原子である場合の化合物(3)として、より具体的には、例えば、トリアルキルシリルクロライド、ジアルキルシリルクロライド、モノアルキルシリルクロライド、トリアリールシリルクロライド、ジアリールシリルクロライド、モノアリールシリルクロライド、ジアルキルモノアリールシリルクロライド、モノアルキルジアリールシリルクロライド、モノアルキルモノアリールシリルクロライド等が挙げられる。
 次に、化合物(2)と化合物(3)とを反応させる方法全般について、説明する。
For example, as the compound (3) when X is a chlorine atom, more specifically, for example, trialkylsilyl chloride, dialkylsilyl chloride, monoalkylsilyl chloride, triarylsilyl chloride, diarylsilyl chloride, monoarylsilyl. Examples thereof include chloride, dialkyl monoarylsilyl chloride, monoalkyldiarylsilyl chloride, monoalkyl monoarylsilyl chloride and the like.
Next, a general method for reacting the compound (2) with the compound (3) will be described.
<化合物(2)と化合物(3)との反応条件>
 化合物(1)は、化合物(2)と化合物(3)とを反応させることにより得られる。
 反応に供する化合物(3)は、1種のみであってもよいし、2種以上であってもよく、目的とする化合物(1)の構造に応じて、適宜選択すればよい。
 化合物(3)を2種以上用いる場合には、それらの組み合わせ及び比率は、目的に応じて適宜調節できる。
<Reaction conditions between compound (2) and compound (3)>
Compound (1) is obtained by reacting compound (2) with compound (3).
The compound (3) to be subjected to the reaction may be only one kind or two or more kinds, and may be appropriately selected depending on the structure of the target compound (1).
When two or more compounds (3) are used, their combinations and ratios can be appropriately adjusted according to the intended purpose.
 なお、本明細書においては、化合物(1)、(2)及び(3)の種類数に関する記載では、特に断りのない限り、立体異性体を考慮していない。 In this specification, the description of the number of types of compounds (1), (2) and (3) does not consider the stereoisomers unless otherwise specified.
 化合物(3)の使用量は、目的とする化合物(1)の構造等に応じて、適宜調節できる。
 例えば、化合物(3)の使用量は、目的とする化合物(1)中の、前記一般式「-SiR」で表される基の数に応じて調節できる。
The amount of compound (3) used can be appropriately adjusted according to the structure of the target compound (1) and the like.
For example, the amount of compound (3) used can be adjusted according to the number of groups represented by the general formula "-SiR 1 R 2 R 3" in the target compound (1).
 例えば、pの値によらず、化合物(3)の使用量が、化合物(2)の使用量に対して、1~2倍モル量である場合には、1分子中の前記一般式「-SiR」で表される基の数が1~2個である化合物(1)が好適に得られる。
 例えば、pの値によらず、化合物(3)の使用量が、化合物(2)の使用量に対して、3~4倍モル量である場合には、1分子中の前記一般式「-SiR」で表される基の数が3~4個である化合物(1)が好適に得られる。
 例えば、pの値によらず、化合物(3)の使用量が、化合物(2)の使用量に対して、5~6倍モル量である場合には、1分子中の前記一般式「-SiR」で表される基の数が5~6個である化合物(1)が好適に得られる。
 例えば、pが0である場合、化合物(3)の使用量が、化合物(2)の使用量に対して、6倍モル量以上である場合には、1分子中の前記一般式「-SiR」で表される基の数が6個である化合物(1)が、より高収率で得られる。この場合、例えば、化合物(3)の前記使用量が10倍モル量以下であると、化合物(3)の過剰使用が抑制される。
 例えば、pが1又は2である場合、化合物(3)の使用量が、化合物(2)の使用量に対して、7~8倍モル量である場合には、1分子中の前記一般式「-SiR」で表される基の数が7~8個である化合物(1)が好適に得られる。
 例えば、pが1である場合、化合物(3)の使用量が、化合物(2)の使用量に対して、8倍モル量以上である場合には、1分子中の前記一般式「-SiR」で表される基の数が8個である化合物(1)が、より高収率で得られる。この場合、例えば、化合物(3)の前記使用量が好ましくは17倍モル量以下、より好ましくは12倍モル量以下であると、化合物(3)の過剰使用が抑制される。
 例えば、pが2である場合、化合物(3)の使用量が、化合物(2)の使用量に対して、9~10倍モル量である場合には、1分子中の前記一般式「-SiR」で表される基の数が9~10個である化合物(1)が好適に得られる。
 例えば、pが2である場合、化合物(3)の使用量が、化合物(2)の使用量に対して、10倍モル量以上である場合には、1分子中の前記一般式「-SiR」で表される基の数が10個である化合物(1)が、より高収率で得られる。この場合、例えば、化合物(3)の前記使用量が14倍モル量以下であると、化合物(3)の過剰使用が抑制される。
For example, regardless of the value of p 1, the amount of the compound (3) is, when the relative amount of the compound (2) is 1 to 2 times molar quantity, the formula in one molecule " A compound (1) having 1 to 2 groups represented by " -SiR 1 R 2 R 3" is preferably obtained.
For example, regardless of the value of p 1, the amount of the compound (3) is, relative to the amount of the compound (2), when it is 3 to 4 times the molar amount of the general formula in a molecule " A compound (1) having 3 to 4 groups represented by " -SiR 1 R 2 R 3" is preferably obtained.
For example, regardless of the value of p 1, the amount of the compound (3) is, relative to the amount of the compound (2), when it is 5-6 times the molar amount of the general formula in a molecule " A compound (1) having 5 to 6 groups represented by " -SiR 1 R 2 R 3" is preferably obtained.
For example, when p 1 is 0 and the amount of compound (3) used is 6 times the molar amount or more of the amount of compound (2) used, the general formula "-" in one molecule The compound (1) having 6 groups represented by " SiR 1 R 2 R 3" can be obtained in a higher yield. In this case, for example, when the amount of the compound (3) used is 10 times the molar amount or less, the excessive use of the compound (3) is suppressed.
For example, when p 1 is 1 or 2, and the amount of compound (3) used is 7 to 8 times the molar amount of compound (2) used, the general amount in one molecule. A compound (1) having 7 to 8 groups represented by the formula “−SiR 1 R 2 R 3” is preferably obtained.
For example, when p 1 is 1, and the amount of compound (3) used is 8 times the molar amount or more of the amount of compound (2) used, the general formula "-" in one molecule. The compound (1) having 8 groups represented by " SiR 1 R 2 R 3" can be obtained in a higher yield. In this case, for example, when the amount of the compound (3) used is preferably 17 times the molar amount or less, more preferably 12 times the molar amount or less, the overuse of the compound (3) is suppressed.
For example, when p 1 is 2, and the amount of compound (3) used is 9 to 10 times the molar amount of compound (2) used, the above general formula "in one molecule" A compound (1) having 9 to 10 groups represented by " -SiR 1 R 2 R 3" is preferably obtained.
For example, when p 1 is 2, and the amount of compound (3) used is 10 times the molar amount or more of the amount of compound (2) used, the general formula "-" in one molecule. The compound (1) having 10 groups represented by " SiR 1 R 2 R 3" can be obtained in a higher yield. In this case, for example, when the amount of the compound (3) used is 14 times the molar amount or less, the excessive use of the compound (3) is suppressed.
 なお、ここまでで説明した化合物(3)の使用量は、目的とする化合物(1)を効率よく、良好な収率で得るための一例であり、化合物(3)の使用量は、化合物(1)の製造条件全般を考慮して、適宜調節できる。
 また、ここまでで説明した化合物(3)の使用量は、2種以上の化合物(3)を用いる場合には、用いる化合物(3)の全種類の合計使用量を意味する。
The amount of the compound (3) used so far is an example for efficiently obtaining the target compound (1) in a good yield, and the amount of the compound (3) used is the compound (3). It can be adjusted as appropriate in consideration of the overall manufacturing conditions of 1).
In addition, the amount of the compound (3) used so far means the total amount of all kinds of the compound (3) used when two or more kinds of the compound (3) are used.
[塩基]
 化合物(2)と化合物(3)との反応時には、塩基を用いることが好ましい。塩基を用いることにより、化合物(1)の生成量が顕著に増大する。
[base]
When the compound (2) and the compound (3) are reacted, it is preferable to use a base. By using a base, the amount of compound (1) produced is significantly increased.
 前記塩基は、有機塩基であることが好ましい。
 前記有機塩基としては、例えば、アニリン、ピリジン、ピペリジン等の芳香族アミン;トリエチルアミン、ジイソプロピルエチルアミン等の脂肪族アミン等が挙げられる。
The base is preferably an organic base.
Examples of the organic base include aromatic amines such as aniline, pyridine and piperidine; and aliphatic amines such as triethylamine and diisopropylethylamine.
 前記塩基を用いる場合、塩基は、1種を単独で用いてもよいし、2種以上を併用してもよく、2種以上を併用する場合、それらの組み合わせ及び比率は、目的に応じて適宜調節できる。 When the above bases are used, one type of base may be used alone, two or more types may be used in combination, and when two or more types are used in combination, the combination and ratio thereof may be appropriately adjusted according to the purpose. Can be adjusted.
 前記塩基を用いる場合、塩基の使用量は、例えば、化合物(3)の使用量に応じて、調節できる。
 その場合、塩基の使用量は、化合物(3)の使用量に対して、1~2倍モル量であることが好ましく、例えば、1~1.5倍モル量であってもよい。塩基の前記使用量が1倍モル量以上であることで、化合物(1)の生成量がより増大する。塩基の前記使用量が2倍モル量以下であることで、塩基の過剰使用が抑制される。
When the base is used, the amount of the base used can be adjusted, for example, according to the amount of the compound (3) used.
In that case, the amount of the base used is preferably 1 to 2 times the molar amount of the compound (3), and may be, for example, 1 to 1.5 times the molar amount. When the amount of the base used is 1 times the molar amount or more, the amount of the compound (1) produced is further increased. When the amount of the base used is twice the molar amount or less, the excessive use of the base is suppressed.
[溶媒]
 化合物(2)と化合物(3)との反応は、溶媒を用いずに行ってもよいが、溶媒を用いて行うことが好ましい。溶媒を用いることにより、反応液の流動性が向上し、化合物(2)と化合物(3)との反応がより円滑に進行し、副生成物の生成量も低減できる。
[solvent]
The reaction between the compound (2) and the compound (3) may be carried out without using a solvent, but it is preferably carried out using a solvent. By using the solvent, the fluidity of the reaction solution is improved, the reaction between the compound (2) and the compound (3) proceeds more smoothly, and the amount of by-products produced can be reduced.
 前記溶媒は、化合物(2)、化合物(3)等の、反応に用いる成分との反応性を有しないものが好ましい。
 前記溶媒としては、例えば、テトラヒドロフラン(THF)、1,4-ジオキサン、テトラヒドロピラン、ジブチルエーテル、1,2-ジメトキシエタン等のエーテル(エーテル結合を有する化合物);N,N-ジメチルホルムアミド(DMF)、N,N-ジメチルアセトアミド(DMAc)等のアミド;酢酸エチル、酢酸ブチル等のエステル;1,2-ジクロロエタン、塩化メチレン、クロロベンゼン等のハロゲン化炭化水素(置換基としてハロゲン原子を有する炭化水素);プロピオニトリル、アセトニトリル等のニトリル(シアノ基を有する化合物);トルエン、n-ヘキサン、メチルシクロヘキサン等の炭化水素等が挙げられる。
The solvent is preferably one that does not have reactivity with the components used in the reaction, such as compound (2) and compound (3).
Examples of the solvent include ethers (compounds having an ether bond) such as tetrahydrofuran (THF), 1,4-dioxane, tetrahydropyran, dibutyl ether, 1,2-dimethoxyethane; N, N-dimethylformamide (DMF). , N, N-Dimethylacetamide (DMAc) and other amides; Ethyl acetate, butyl acetate and other esters; 1,2-Dichloroethane, methylene chloride, chlorobenzene and other halogenated hydrocarbons (hydrocarbons having a halogen atom as a substituent) Nitriles such as propionitrile and acetonitrile (compounds having a cyano group); hydrocarbons such as toluene, n-hexane and methylcyclohexane can be mentioned.
 溶媒を用いる場合、前記溶媒は、1種を単独で用いてもよいし、2種以上を併用してもよく、2種以上を併用する場合、それらの組み合わせ及び比率は、目的に応じて適宜調節できる。 When a solvent is used, one type of the solvent may be used alone, two or more types may be used in combination, and when two or more types are used in combination, the combination and ratio thereof may be appropriately adjusted according to the purpose. Can be adjusted.
 溶媒の使用量は、特に限定されないが、例えば、化合物(2)の使用量1mmolに対して、0~100mlであることが好ましく、10~50mlであることがより好ましい。溶媒の前記使用量が10ml以上であることで、溶媒を用いたことによる効果がより顕著に得られる。溶媒の前記使用量が100ml以下であることで、溶媒の過剰使用が抑制される。 The amount of the solvent used is not particularly limited, but for example, it is preferably 0 to 100 ml, more preferably 10 to 50 ml, with respect to 1 mmol of the compound (2) used. When the amount of the solvent used is 10 ml or more, the effect of using the solvent can be obtained more remarkably. When the amount of the solvent used is 100 ml or less, the excessive use of the solvent is suppressed.
[他の成分]
 化合物(2)と化合物(3)との反応時には、本発明の効果を損なわない範囲内において、化合物(2)と、化合物(3)と、前記塩基と、前記溶媒と、のいずれにも該当しない他の成分を用いてもよい。
 前記他の成分の種類は、特に限定されず、目的に応じて任意に選択できる。
[Other ingredients]
When the compound (2) and the compound (3) are reacted, the compound (2), the compound (3), the base, and the solvent are all applicable as long as the effects of the present invention are not impaired. Other ingredients may be used.
The type of the other component is not particularly limited and can be arbitrarily selected depending on the intended purpose.
 前記他の成分を用いる場合、前記他の成分は、1種を単独で用いてもよいし、2種以上を併用してもよく、2種以上を併用する場合、それらの組み合わせ及び比率は、目的に応じて適宜調節できる。 When the other component is used, one type of the other component may be used alone, two or more types may be used in combination, and when two or more types are used in combination, the combination and ratio thereof shall be determined. It can be adjusted as appropriate according to the purpose.
 前記他の成分を用いる場合、前記他の成分の使用量は、特に限定されず、前記他の成分の種類に応じて、任意に選択できる。 When the other component is used, the amount of the other component used is not particularly limited and can be arbitrarily selected according to the type of the other component.
[他の反応条件]
 化合物(2)と化合物(3)との反応時における反応温度は、適宜調節すればよく、特に限定されない。
 反応温度は、10~40℃であることが好ましく、例えば、18~30℃等の室温であってもよい。
[Other reaction conditions]
The reaction temperature at the time of the reaction between the compound (2) and the compound (3) may be appropriately adjusted and is not particularly limited.
The reaction temperature is preferably 10 to 40 ° C, and may be room temperature such as 18 to 30 ° C.
 化合物(2)と化合物(3)との反応時における反応時間は、化合物(1)の生成量が増大するように、反応温度等、他の条件に応じて適宜調節すればよく、特に限定されない。
 反応時間は、例えば、1~72時間であることが好ましく、1~60時間であることがより好ましい。
The reaction time during the reaction between the compound (2) and the compound (3) may be appropriately adjusted according to other conditions such as the reaction temperature so that the amount of the compound (1) produced is increased, and is not particularly limited. ..
The reaction time is, for example, preferably 1 to 72 hours, more preferably 1 to 60 hours.
 本実施形態においては、反応終了後、必要に応じて公知の手法によって後処理を行った後、公知の手法によって化合物(1)を取り出すことができる。
 例えば、反応終了後、適宜必要に応じて、ろ過、洗浄、抽出、pH調整、脱水、濃縮等の後処理操作をいずれか単独で、又は2種以上組み合わせて行い、次いで、濃縮、結晶化、再沈殿、カラムクロマトグラフィー等により、化合物(1)を取り出すことができる。また、取り出した化合物(1)は、さらに必要に応じて、結晶化、再沈殿、カラムクロマトグラフィー、抽出、溶媒による結晶の撹拌洗浄等の操作をいずれか単独で、又は2種以上組み合わせて、1回又は2回以上行うことによって、精製してもよい。
 反応終了後に、化合物(1)を用いる他の工程を引き続き行う場合には、反応終了後に、必要に応じて公知の手法によって後処理を行った後、化合物(1)を取り出すことなく、引き続き前記他の工程を行ってもよい。
In the present embodiment, after completion of the reaction, if necessary, post-treatment is carried out by a known method, and then compound (1) can be taken out by a known method.
For example, after completion of the reaction, post-treatment operations such as filtration, washing, extraction, pH adjustment, dehydration, and concentration are performed individually or in combination of two or more, as needed, and then concentration, crystallization, and so on. Compound (1) can be extracted by reprecipitation, column chromatography, or the like. Further, the extracted compound (1) can be further subjected to operations such as crystallization, reprecipitation, column chromatography, extraction, and stirring and washing of crystals with a solvent, either alone or in combination of two or more, if necessary. It may be purified by performing it once or twice or more.
When another step using compound (1) is to be continued after the reaction is completed, after the reaction is completed, post-treatment is carried out by a known method as necessary, and then the compound (1) is not taken out. Other steps may be performed.
 化合物(2)と化合物(3)との反応によって、複数種の化合物(1)が生成している場合、上述の後処理操作及び精製操作のいずれか一方又は両方を、適宜選択して行うことにより、目的とする化合物(1)を得られる。複数種の化合物(1)が生成していても、化合物(1)の構造からその特性を推測できるため、その特性に適した後処理操作又は精製操作を選択することにより、目的とする化合物(1)の収率を向上させることができる。
 また、化合物(3)の使用量、その他の反応条件等を調節することで、目的とする化合物(1)の生成率を向上させることによって、化合物(1)の収率を向上させることができる。
When a plurality of types of the compound (1) are produced by the reaction of the compound (2) and the compound (3), one or both of the above-mentioned post-treatment operation and purification operation should be appropriately selected and performed. The desired compound (1) can be obtained. Even if a plurality of types of the compound (1) are produced, its characteristics can be inferred from the structure of the compound (1). Therefore, by selecting a post-treatment operation or a purification operation suitable for the characteristics, the target compound ( The yield of 1) can be improved.
Further, the yield of the compound (1) can be improved by improving the production rate of the target compound (1) by adjusting the amount of the compound (3) used, other reaction conditions and the like. ..
 化合物(1)の構造は、例えば、核磁気共鳴(NMR)分光法、質量分析法(MS)、赤外分光法(IR)、紫外・可視分光法(UV-VIS吸収スペクトル)、元素分析法等の公知の手法によって、確認できる。 The structure of compound (1) is, for example, nuclear magnetic resonance (NMR) spectroscopy, mass spectrometry (MS), infrared spectroscopy (IR), ultraviolet / visible spectroscopy (UV-VIS absorption spectrum), elemental analysis. It can be confirmed by a known method such as.
<<化合物>>
 本発明の一実施形態に係る化合物は、下記一般式(10):
<< Compound >>
The compound according to one embodiment of the present invention has the following general formula (10):
Figure JPOXMLDOC01-appb-C000052
 (式中、pは0、1又は2であり;Z10は、水素原子又は一般式「-SiR102030」で表される基であり、(2p+6)個のZ10は互いに同一でも異なっていてもよく、ただし、1個又は2個以上のZ10は、前記一般式「-SiR102030」で表される基であり;R10、R20及びR30は、それぞれ独立に、水素原子、又は置換基を有していてもよいアルキル基若しくはアリール基であり、R10、R20及びR30のうちの2個以上が前記アルキル基又はアリール基である場合、これら基は相互に結合して環を形成していてもよい。)
で表される(ただし、pが1であり、8個のZ10がすべて式「-Si(CH」、式「-Si(CHH」、式「-Si((4-CH)C)(CH」、式「-Si((4-CBr)C)(CH」、式「-Si((4-COOH)C)(CH」、式「-Si(CH(OSi(CH)」、式「-Si(CH(CH=CH)」、式「-Si(CH=CH」、式「-Si(CHCHCl」、又は式「-Si(CH(OSi(CH)」で表される基である化合物と、pが1であり、7個のZ10が式「-Si(CH」で表される基であり、1個のZ10が水素原子である化合物と、pが1であり、6個のZ10が式「-Si(CH」で表される基であり、2個のZ10が水素原子である化合物と、pが1であり、5個のZ10が式「-Si(CH」で表される基であり、3個のZ10が水素原子である化合物と、を除く)。
Figure JPOXMLDOC01-appb-C000052
(In the formula, p 1 is 0, 1 or 2; Z 10 is a hydrogen atom or a group represented by the general formula "-SiR 10 R 20 R 30 ", and (2p 1 + 6) Z 10s. May be the same or different from each other, except that one or more Z 10s are groups represented by the general formula "-SiR 10 R 20 R 30 "; R 10 , R 20 and R. Reference numeral 30 denotes an alkyl group or an aryl group which may independently have a hydrogen atom or a substituent, and two or more of R 10 , R 20 and R 30 are the alkyl group or the aryl group. In some cases, these groups may be bonded to each other to form a ring.)
(However, p 1 is 1, and all eight Z 10s are represented by the formula "-Si (CH 3 ) 3 ", the formula "-Si (CH 3 ) 2 H", and the formula "-Si ((((CH 3) 3) 3". 4-CH 3 ) C 6 H 4 ) (CH 3 ) 2 ", formula" -Si ((4-CBr 3 ) C 6 H 4 ) (CH 3 ) 2 ", formula" -Si ((4-COOH)) C 6 H 4 ) (CH 3 ) 2 ”, formula“ -Si (CH 3 ) 2 (OSi (CH 3 ) 3 ) ”, formula“ -Si (CH 3 ) 2 (CH = CH 2 ) ”, formula“ -Si (CH = CH 2 ) 3 ", the formula" -Si (CH 3 ) 2 CH 2 Cl ", or the group represented by the formula" -Si (CH 3 ) 2 (OSi (CH 3 ) 3) " A compound, a compound in which p 1 is 1, seven Z 10s are groups represented by the formula "-Si (CH 3 ) 3 ", and one Z 10 is a hydrogen atom, and p 1 Is 1, 6 Z 10s are groups represented by the formula "-Si (CH 3 ) 3 ", 2 Z 10s are hydrogen atoms, and p 1 is 1 and 5 number of Z 10 is the formula "-Si (CH 3) 3" is a group represented by, except three Z 10 is a compound which is a hydrogen atom, a).
 本実施形態の化合物(本明細書においては、「化合物(10)」と称することがある)は、機能性ケイ素材料として利用可能であり、有用性が高い。 The compound of the present embodiment (in this specification, may be referred to as "compound (10)") can be used as a functional silicon material and is highly useful.
 一般式(10)中、pは、化合物(10)のかごのサイズを規定しており、0、1又は2である。
 一般式(10)中のpは、先に説明した一般式(1)中のpと同じである。
In the general formula (10), p 1 is to define the size of the cage of the compound (10), is 0, 1 or 2.
The p 1 in the general formula (10) is the same as the p 1 in the general formula (1) described above.
 化合物(10)は、pが1であり、8個のZ10がすべて式「-Si(CH」で表される基である化合物と、pが1であり、8個のZ10がすべて式「-Si(CHH」で表される基である化合物と、pが1であり、8個のZ10がすべて式「-Si((4-CH)C)(CH」で表される基である化合物と、pが1であり、8個のZ10がすべて式「-Si((4-CBr)C)(CH」で表される基である化合物と、pが1であり、8個のZ10がすべて式「-Si((4-COOH)C)(CH」で表される基である化合物と、を含まない点を除けば、先に説明した化合物(1)と同じである。
 すなわち、pが0である場合の化合物(10)は、下記一般式(101)で表され、pが1である場合の化合物(10)は、下記一般式(102)で表され、pが2である場合の化合物(10)は、下記一般式(103)で表される。
Compound (10) has a compound (10) in which p 1 is 1 and all eight Z 10s are groups represented by the formula “-Si (CH 3 ) 3 ”, and compound (10) has p 1 in 1 and eight. A compound in which all Z 10s are groups represented by the formula "-Si (CH 3 ) 2 H" and p 1 is 1, and all eight Z 10s are all represented by the formula "-Si ((4-CH 3 )). The compound which is the group represented by " C 6 H 4 ) (CH 3 ) 2 ", p 1 is 1, and all eight Z 10s are of the formula "-Si ((4-CBr 3 ) C 6 H 4". ) (CH 3 ) 2 ”, p 1 is 1, and all eight Z 10s are of the formula“ −Si ((4-COOH) C 6 H 4 ) (CH 3 ). It is the same as the compound (1) described above except that it does not contain the compound which is the group represented by "2".
That is, the compound (10) when p 1 is 0 is represented by the following general formula (101), and the compound (10) when p 1 is 1 is represented by the following general formula (102). The compound (10) when p 1 is 2 is represented by the following general formula (103).
Figure JPOXMLDOC01-appb-C000053
 (式中、Z10は、上記と同じである。)
Figure JPOXMLDOC01-appb-C000053
(In the formula, Z 10 is the same as above.)
 一般式(10)中のZ10は、「pが1である場合に、8個のZ10がすべて式「-Si(CH」で表される基とはならない」、「pが1である場合に、8個のZ10がすべて式「-Si(CHH」で表される基とはならない」、「pが1である場合に、8個のZ10がすべて式「-Si((4-CH)C)(CH」で表される基(ジメチル(4-メチルフェニル)シリル基)とはならない」、「pが1である場合に、8個のZ10がすべて式「-Si((4-CBr)C)(CH」で表される基(4-トリブロモメチルフェニル(ジメチル)シリル基)とはならない」、「pが1である場合に、8個のZ10がすべて式「-Si((4-COOH)C)(CH」で表される基(4-カルボキシフェニル(ジメチル)シリル基)とはならない」、「pが1である場合に、8個のZ10がすべて式「-Si(CH(OSi(CH)」で表される基とはならない」、「pが1である場合に、8個のZ10がすべて式「-Si(CH(CH=CH)」で表される基とはならない」、「pが1である場合に、8個のZ10がすべて式「-Si(CH=CH」で表される基とはならない」、「pが1である場合に、8個のZ10がすべて式「-Si(CHCHCl」で表される基とはならない」、「pが1である場合に、8個のZ10がすべて式「-Si(CH(OSi(CH)」で表される基とはならない」、「pが1である場合に、7個のZ10が式「-Si(CH」で表される基であり、かつ1個のZ10が水素原子である、とはならない」、「pが1である場合に、6個のZ10が式「-Si(CH」で表される基であり、かつ2個のZ10が水素原子である、とはならない」、及び「pが1である場合に、5個のZ10が式「-Si(CH」で表される基であり、かつ3個のZ10が水素原子である、とはならない」、というすべての条件を満たす点を除けば、先に説明した一般式(1)中のZと同じである。
 例えば、一般式(10)中、(2p+6)個のZ10は互いに同一でも異なっていてもよく、ただし、1個又は2個以上のZ10は、前記一般式「-SiR102030」で表される基である。
Z 10 in the general formula (10) is "when p 1 is 1, all eight Z 10s are not groups represented by the formula" -Si (CH 3 ) 3 "", "p. When 1 is 1, all 8 Z 10s are not groups represented by the formula "-Si (CH 3 ) 2 H""," 8 Z when p 1 is 1. All 10 are not groups represented by the formula "-Si ((4-CH 3 ) C 6 H 4 ) (CH 3 ) 2 " (dimethyl (4-methylphenyl) silyl group) "," p 1 is When 1, all eight Z 10s are groups represented by the formula "-Si ((4-CBr 3 ) C 6 H 4 ) (CH 3 ) 2 " (4-tribromomethylphenyl (dimethyl)). It does not become a silyl group) "," When p 1 is 1, all eight Z 10s are represented by the formula "-Si ((4-COOH) C 6 H 4 ) (CH 3 ) 2 ". It does not form a group (4-carboxyphenyl (dimethyl) silyl group) "," When p 1 is 1, all eight Z 10s are of the formula "-Si (CH 3 ) 2 (OSi (CH 3 ) 3 ). ) ”,“ When p 1 is 1, all eight Z 10s are groups represented by the formula “−Si (CH 3 ) 2 (CH = CH 2)”. "When p 1 is 1, all eight Z 10s are not groups represented by the formula" -Si (CH = CH 2 ) 3 "", "p 1 is 1. In some cases, all eight Z 10s are not groups represented by the formula "-Si (CH 3 ) 2 CH 2 Cl""," When p 1 is 1, eight Z 10s are All are not groups represented by the formula "-Si (CH 3 ) 2 (OSi (CH 3 ) 3 )"", "When p 1 is 1, seven Z 10s are the formula" -Si ( CH 3 ) It is a group represented by " 3 ", and one Z 10 is not a hydrogen atom. "," When p 1 is 1, six Z 10s are of the formula "-Si." (CH 3 ) 3 "is a group represented by" and two Z 10s are not hydrogen atoms ", and" when p 1 is 1, five Z 10s are of the formula " -Si (CH 3 ) 3 "is a group represented by", and three Z 10s are not hydrogen atoms ", except that the general formula described above is satisfied. It is the same as Z 1 in (1).
For example, in the general formula (10), (2p 1 + 6) Z 10s may be the same or different from each other, except that one or two or more Z 10s are described in the general formula “−SiR 10 R 20”. It is a group represented by "R 30".
 一般式(10)中のR10、R20及びR30は、それぞれ、先に説明した一般式(1)中のR、R及びRと同じである。
 例えば、R10、R20及びR30のうちの2個以上(2個又は3個)が前記アルキル基又はアリール基である場合、これら基(アルキル基又はアリール基)は、これら基が結合しているケイ素原子(Si)とともに環を形成していてもよい。
R 10 , R 20 and R 30 in the general formula (10) are the same as R 1 , R 2 and R 3 in the general formula (1) described above, respectively.
For example, when two or more (two or three) of R 10 , R 20 and R 30 are the above-mentioned alkyl group or aryl group, these groups (alkyl group or aryl group) are bonded to these groups. A ring may be formed together with the silicon atom (Si).
 好ましい化合物(10)の一例としては、R10、R20及びR30が、それぞれ独立に、水素原子、炭素数1~20のアルキル基(炭素数1~20の直鎖状又は分岐鎖状のアルキル基、炭素数3~20の環状のアルキル基)又は炭素数6~20のアリール基であるものが挙げられる。このような化合物(10)のR10、R20及びR30においては、前記アルキル基又はアリール基が置換基を有していてもよい。 As an example of the preferred compound (10), R 10 , R 20 and R 30 are independently hydrogen atoms and alkyl groups having 1 to 20 carbon atoms (linear or branched chains having 1 to 20 carbon atoms). Alkyl groups (cyclic alkyl groups having 3 to 20 carbon atoms) or aryl groups having 6 to 20 carbon atoms can be mentioned. In R 10 , R 20 and R 30 of such compound (10), the alkyl group or aryl group may have a substituent.
 より好ましい化合物(10)の一例としては、R10、R20及びR30が、それぞれ独立に、水素原子、炭素数1~6のアルキル基(炭素数1~6の直鎖状又は分岐鎖状のアルキル基、炭素数3~6の環状のアルキル基)又は炭素数6~12のアリール基であるものが挙げられる。このような化合物(10)のR10、R20及びR30においては、前記アルキル基又はアリール基が置換基を有していてもよい。 As an example of the more preferable compound (10), R 10 , R 20 and R 30 are independently hydrogen atoms and alkyl groups having 1 to 6 carbon atoms (linear or branched chains having 1 to 6 carbon atoms, respectively). , A cyclic alkyl group having 3 to 6 carbon atoms) or an aryl group having 6 to 12 carbon atoms. In R 10 , R 20 and R 30 of such compound (10), the alkyl group or aryl group may have a substituent.
 特に好ましい化合物(10)の一例としては、pが0である場合の、下記一般式(1011): As an example of a particularly preferable compound (10), the following general formula (1011): When p 1 is 0:
Figure JPOXMLDOC01-appb-C000054
 (式中、Z11は、水素原子又は一般式「-SiR112131」で表される基であり、6個のZ11は互いに同一でも異なっていてもよく、ただし、1個又は2個以上のZ11は、前記一般式「-SiR112131」で表される基であり;R11、R21及びR31は、それぞれ独立に、水素原子、炭素数1~6のアルキル基又は炭素数6~12のアリール基であり、R11、R21及びR31のうちの2個以上が前記アルキル基又はアリール基である場合、これら基は相互に結合して環を形成していてもよい。)
で表される化合物が挙げられる。
Figure JPOXMLDOC01-appb-C000054
(In the formula, Z 11 is a hydrogen atom or a group represented by the general formula "-SiR 11 R 21 R 31 ", and the six Z 11s may be the same or different from each other, but one or one. the two or more Z 11, formula "-SiR 11 R 21 R 31" in be a group represented by; R 11, R 21 and R 31 are independently a hydrogen atom, 6 When two or more of R 11 , R 21 and R 31 are the alkyl groups or aryl groups of the above alkyl groups or aryl groups having 6 to 12 carbon atoms, these groups are bonded to each other to form a ring. It may be formed.)
Examples thereof include compounds represented by.
 一般式(1011)中のR11、R21及びR31は、アルキル基及びアリール基において、それぞれ炭素数が限定されている点と、それぞれ置換基を有しない点と、を除けば、先に説明した一般式(1)中のR、R及びRと同じである。
 例えば、R11、R21及びR31のうちの2個以上(2個又は3個)が前記アルキル基又はアリール基である場合、これら基(アルキル基又はアリール基)は、これら基が結合しているケイ素原子(Si)とともに、環を形成していてもよい。
R 11 , R 21 and R 31 in the general formula (1011) are first described except that the alkyl group and the aryl group each have a limited number of carbon atoms and do not have a substituent. It is the same as R 1 , R 2 and R 3 in the general formula (1) described.
For example, when two or more (two or three) of R 11 , R 21 and R 31 are the above-mentioned alkyl group or aryl group, these groups (alkyl group or aryl group) are bonded to these groups. A ring may be formed together with the silicon atom (Si).
 一般式(1011)中のZ11は、アルキル基及びアリール基において、それぞれ炭素数が限定されている点と、それぞれ置換基を有しない点と、を除けば、先に説明した一般式(1)中のZと同じである。 Z 11 in the general formula (1011) has the above-described general formula (1) except that the alkyl group and the aryl group each have a limited number of carbon atoms and each has no substituent. ) Is the same as Z 1 in.
 また、特に好ましい化合物(10)の他の例としては、pが1である場合の、下記一般式(1021): Further, as another example of the particularly preferable compound (10), when p 1 is 1, the following general formula (1021):
Figure JPOXMLDOC01-appb-C000055
 (式中、Z11は、上記と同じであり、8個のZ11は互いに同一でも異なっていてもよく、ただし、1個又は2個以上のZ11は、前記一般式「-SiR112131」で表される基である。)
で表される化合物(ただし、8個のZ11がすべて式「-Si(CH」、式「-Si(CHH」、式「-Si((4-CH)C)(CH」、式「-Si((4-CBr)C)(CH」、式「-Si((4-COOH)C)(CH」、式「-Si(CH(OSi(CH)」、式「-Si(CH(CH=CH)」、式「-Si(CH=CH」、式「-Si(CHCHCl」、又は式「-Si(CH(OSi(CH)」で表される基である化合物と、7個のZ11が式「-Si(CH」で表される基であり、1個のZ11が水素原子である化合物と、6個のZ11が式「-Si(CH」で表される基であり、2個のZ11が水素原子である化合物と、5個のZ11が式「-Si(CH」で表される基であり、3個のZ11が水素原子である化合物と、を除く)が挙げられる。
Figure JPOXMLDOC01-appb-C000055
(Wherein, Z 11 are the same as described above, may be the same or different from each other 8 Z 11, provided that one or more of Z 11, the formula "-SiR 11 R It is a group represented by " 21 R 31".)
Compound represented by (where eight Z 11 are all expressions "-Si (CH 3) 3", the formula "-Si (CH 3) 2 H", the formula "-Si ((4-CH 3) C 6 H 4 ) (CH 3 ) 2 ”, formula“ -Si ((4-CBr 3 ) C 6 H 4 ) (CH 3 ) 2 ”, formula“ -Si ((4-COOH) C 6 H 4 ) ( CH 3 ) 2 ”, formula“ -Si (CH 3 ) 2 (OSi (CH 3 ) 3 ) ”, formula“ -Si (CH 3 ) 2 (CH = CH 2 ) ”, formula“ -Si (CH = CH) 2 ) 3 ", the compound which is the group represented by the formula" -Si (CH 3 ) 2 CH 2 Cl ", or the formula" -Si (CH 3 ) 2 (OSi (CH 3 ) 3) ", and 7 pieces. the Z 11 is a group represented by the formula "-Si (CH 3) 3", and one of Z 11 is a hydrogen atom compound, 6 Z 11 is the formula "-Si (CH 3) 3 a group represented by "and two Z 11 compound is a hydrogen atom, a group five Z 11 represented by the formula" -Si (CH 3) 3 ', 3 Z ( Excluding compounds in which 11 is a hydrogen atom).
 また、特に好ましい化合物(10)の他の例としては、pが2である場合の、下記一般式(1031): Further, as another example of the particularly preferable compound (10), when p 1 is 2, the following general formula (1031):
Figure JPOXMLDOC01-appb-C000056
 (式中、Z11は、上記と同じであり、10個のZ11は互いに同一でも異なっていてもよく、ただし、1個又は2個以上のZ11は、前記一般式「-SiR112131」で表される基である。)
で表される化合物が挙げられる。
Figure JPOXMLDOC01-appb-C000056
(Wherein, Z 11 is the same as above, 10 Z 11 may be the same or different, provided that one or more of Z 11, the formula "-SiR 11 R It is a group represented by " 21 R 31".)
Examples thereof include compounds represented by.
 好ましい化合物(10)の例としては、先に列挙した好ましい化合物(1)と同じもの(ただし、前記一般式(10)において、pが1であり、8個のZ10がすべて式「-Si(CH」で表される基であるものに相当する化合物と、pが1であり、8個のZ10がすべて式「-Si(CHH」で表される基であるものに相当する化合物と、pが1であり、7個のZ10が式「-Si(CH」で表される基であり、1個のZ10が水素原子であるものに相当する化合物と、pが1であり、6個のZ10が式「-Si(CH」で表される基であり、2個のZ10が水素原子であるものに相当する化合物と、pが1であり、5個のZ10が式「-Si(CH」で表される基であり、3個のZ10が水素原子であるものに相当する化合物と、を除く)が挙げられる。 Examples of the preferred compound (10) are the same as those of the preferred compound (1) listed above (however, in the general formula (10), p 1 is 1 and all eight Z 10s are of the formula "-". The compound corresponding to the group represented by "Si (CH 3 ) 3 ", p 1 is 1, and all eight Z 10s are represented by the formula "-Si (CH 3 ) 2 H". A compound corresponding to the group, p 1 is 1, seven Z 10s are groups represented by the formula "-Si (CH 3 ) 3 ", and one Z 10 is a hydrogen atom. A compound corresponding to a certain compound, p 1 is 1, six Z 10s are groups represented by the formula "-Si (CH 3 ) 3 ", and two Z 10s are hydrogen atoms. Corresponds to a compound corresponding to, p 1 is 1, five Z 10s are groups represented by the formula "-Si (CH 3 ) 3 ", and three Z 10s are hydrogen atoms. (Except for compounds that are used).
 化合物(10)は、先に説明した、本発明の一実施形態に係る化合物の製造方法によって製造できる。 Compound (10) can be produced by the method for producing a compound according to an embodiment of the present invention, which has been described above.
 以下、具体的実施例により、本発明についてより詳細に説明する。ただし、本発明は、以下に示す実施例に、何ら限定されるものではない。 Hereinafter, the present invention will be described in more detail with reference to specific examples. However, the present invention is not limited to the examples shown below.
 本実施例で用いている略称の意味を以下に示す。
 DMAc:N,N-ジメチルアセトアミド
 THF:テトラヒドロフラン
 Me:メチル基
 Bu:n-ブチル基
 Ph:フェニル基
The meanings of the abbreviations used in this example are shown below.
DMAc: N, N-dimethylacetamide THF: tetrahydrofuran Me: Methyl group n Bu: n-Butyl group Ph: Phenyl group
 以下に示す化合物(1)の収率は、化合物(2)を基準としている。
 以下において、「mmol」は「10-3モル」を示す。
 以下においては、化合物(1)、化合物(2)の個々の化合物の名称を、これら化合物を表す式に付した符号を用いて決定している。例えば、後述する「式(1021)-1で表される化合物」は、「化合物(1021)-1」と称する。
The yield of compound (1) shown below is based on compound (2).
In the following, "mmol" represents " 10-3 mol".
In the following, the names of the individual compounds of the compound (1) and the compound (2) are determined by using the reference numerals given to the formulas representing these compounds. For example, the "compound represented by the formula (1021) -1" described later is referred to as "compound (1021) -1".
<<化合物(1)の製造>>
[実施例1]
 化合物(2)として、DMAcを含む混合結晶である化合物(22)-1を用い、化合物(1)として化合物(1021)-1を製造した。より具体的には、以下のとおりである。
 化合物(22)-1(311mg、0.20mmol)をTHF(6ml)に溶解させ、得られた溶液に、アニリン(176mg、2.4mmol)とフェニルジヒドロクロロシラン(285mg、2.0mmol)を加えて、室温で2時間撹拌することで、懸濁溶液を得た。この懸濁溶液の各種NMRスペクトルから、化合物(1021)-1(組成式:Si16204856、「Si12[OSiPhH」)が生成していることを確認した。
 この懸濁溶液にヘキサン(12ml)を加えて塩をろ別した後、得られたろ液を水洗し、硫酸マグネシウムを加えて乾燥させた後、ろ別した。
 得られたろ液から溶媒を減圧留去した後、クーゲルロアー蒸留(8-18Pa、100℃、1時間)により、残留物から低沸点成分を留去することで、化合物(1021)-1を無色油状物として得た(収量258mg、収率86%)。
 得られた化合物(1021)-1のNMRデータを以下に示す。
<< Production of compound (1) >>
[Example 1]
Compound (22) -1, which is a mixed crystal containing DMAc, was used as compound (2), and compound (1021) -1 was produced as compound (1). More specifically, it is as follows.
Compound (22) -1 (311 mg, 0.20 mmol) was dissolved in THF (6 ml), and aniline (176 mg, 2.4 mmol) and phenyldihydrochlorosilane (285 mg, 2.0 mmol) were added to the obtained solution. , Stirred at room temperature for 2 hours to obtain a suspended solution. From various NMR spectra of this suspension solution, it was confirmed that compound (1021) -1 (composition formula: Si 16 O 20 C 48 H 56 , "Si 8 O 12 [OSiPhH 2 ] 8 ") was produced. ..
Hexane (12 ml) was added to this suspension solution and the salt was filtered off. The obtained filtrate was washed with water, magnesium sulfate was added and dried, and then the filtrate was filtered off.
The solvent was distilled off from the obtained filtrate under reduced pressure, and then the low boiling point component was distilled off from the residue by Kugel lower distillation (8-18 Pa, 100 ° C., 1 hour) to make compound (1021) -1 colorless. Obtained as an oil (yield 258 mg, yield 86%).
The NMR data of the obtained compound (1021) -1 is shown below.
 H-NMR(Benzene-d):5.20ppm、7.10ppm、7.54ppm.
 13C-NMR(Benzene-d):128.4ppm、130.9ppm、133.0ppm、134.3ppm.
 29Si-NMR(Benzene-d):-25.7ppm、-107.8ppm.
1 1 H-NMR (Benzene-d 6 ): 5.20 ppm, 7.10 ppm, 7.54 ppm.
13 C-NMR (Benzene-d 6 ): 128.4 ppm, 130.9 ppm, 133.0 ppm, 134.3 ppm.
29 Si-NMR (Benzene-d 6 ): -25.7 ppm, -107.8 ppm.
Figure JPOXMLDOC01-appb-C000057
Figure JPOXMLDOC01-appb-C000057
[実施例2]
 化合物(2)として、DMAcを含む混合結晶である化合物(22)-2を用い、化合物(1)として化合物(1021)-2を製造した。より具体的には、以下のとおりである。
 化合物(22)-2(106mg、0.10mmol)をTHF(3ml)に溶解させ、得られた溶液に、アニリン(78.5mg、0.84mmol)とクロロジメチルシラン(79.6mg、0.84mmol)を加えて、室温で90分撹拌することで、懸濁溶液を得た。この懸濁溶液の各種NMRスペクトルから、化合物(1021)-2(「Si12[OSiMeH]」)が生成していることを確認した。
 この懸濁溶液にヘキサン(6ml)を加えて塩をろ別した。
 得られたろ液から溶媒を減圧留去することで、化合物(1021)-2を固体物として得た(収量80.0mg、収率77%)。
 得られた化合物(1021)-2のNMRデータを以下に示す。
[Example 2]
Compound (22) -2, which is a mixed crystal containing DMAc, was used as compound (2), and compound (1021) -2 was produced as compound (1). More specifically, it is as follows.
Compound (22) -2 (106 mg, 0.10 mmol) was dissolved in THF (3 ml), and aniline (78.5 mg, 0.84 mmol) and chlorodimethylsilane (79.6 mg, 0.84 mmol) were added to the obtained solution. ) Was added, and the mixture was stirred at room temperature for 90 minutes to obtain a suspended solution. From various NMR spectra of this suspension solution, it was confirmed that compound (1021) -2 ("Si 8 O 12 [OSiMe 2 H] 8 ") was produced.
Hexane (6 ml) was added to this suspension solution and the salt was filtered off.
By distilling off the solvent from the obtained filtrate under reduced pressure, compound (1021) -2 was obtained as a solid (yield 80.0 mg, yield 77%).
The NMR data of the obtained compound (1021) -2 is shown below.
 H-NMR(CDCl):0.26ppm、4.73ppm.
 13C-NMR(CDCl):0.08ppm.
 29Si-NMR(CDCl):-1.4ppm、-108.7ppm.
1 1 H-NMR (CDCl 3 ): 0.26 ppm, 4.73 ppm.
13 C-NMR (CDCl 3 ): 0.08 ppm.
29 Si-NMR (CDCl 3 ): −1.4 ppm, −108.7 ppm.
Figure JPOXMLDOC01-appb-C000058
Figure JPOXMLDOC01-appb-C000058
[実施例3]
 化合物(2)として、DMAcを含む混合結晶である化合物(22)-3を用い、化合物(1)として化合物(1021)-3と化合物(1021)-4を製造した。より具体的には、以下のとおりである。
 アニリン(140mg、1.5mmol)とTHF(2ml)を混合し、濃度が0.70mmol/mlであるアニリン溶液を調製した。
 別途、クロロトリメチルシラン(163mg、1.5mmol)とTHF(2ml)を混合し、濃度が0.68mmol/mlであるクロロトリメチルシラン溶液を調製した。
 化合物(22)-3の(29mg、0.02mmol)をTHF(0.5ml)に溶解させ、ここへ、上記で得られたアニリン溶液(214μl、アニリンとして14.0mg、0.15mmol)を加えることにより、溶液Aを得た。
 別途、THF(2ml)と、上記で得られたクロロトリメチルシラン溶液(219μl、クロロトリメチルシランとして16.3mg、0.15mmol)と、を混合することにより、溶液Bを得た。
 室温下で、溶液Aを撹拌しながら、ここへ溶液Bを加えて反応させた。この間、反応液は当初透明であったが徐々に白濁した。
 反応開始から23時間後に、この反応液にさらに、上記で得られたアニリン溶液(14μl、アニリンとして0.9mg、0.01mmol)と、上記で得られたクロロトリメチルシラン溶液(16μl、クロロトリメチルシランとして1.1mg、0.01mmol)と、を加え、室温下でさらに23時間反応させることにより、化合物(1021)-3と化合物(1021)-4を主要生成物とする混合物を得た。
 得られた化合物(1021)-3と化合物(1021)-4のNMRデータを以下に示す。
[Example 3]
Compound (22) -3, which is a mixed crystal containing DMAc, was used as compound (2), and compound (1021) -3 and compound (1021) -4 were produced as compound (1). More specifically, it is as follows.
Aniline (140 mg, 1.5 mmol) and THF (2 ml) were mixed to prepare an aniline solution having a concentration of 0.70 mmol / ml.
Separately, chlorotrimethylsilane (163 mg, 1.5 mmol) and THF (2 ml) were mixed to prepare a chlorotrimethylsilane solution having a concentration of 0.68 mmol / ml.
(29 mg, 0.02 mmol) of compound (22) -3 is dissolved in THF (0.5 ml), and the aniline solution (214 μl, 14.0 mg, 0.15 mmol as aniline) obtained above is added thereto. As a result, solution A was obtained.
Separately, THF (2 ml) and the chlorotrimethylsilane solution (219 μl, 16.3 mg as chlorotrimethylsilane, 0.15 mmol) obtained above were mixed to obtain a solution B.
At room temperature, solution B was added and reacted while stirring solution A. During this period, the reaction solution was initially transparent, but gradually became cloudy.
Twenty-three hours after the start of the reaction, the reaction solution was further added with the above-mentioned aniline solution (14 μl, 0.9 mg as aniline, 0.01 mmol) and the above-mentioned chlorotrimethylsilane solution (16 μl, chlorotrimethylsilane). As a major product, a mixture of compound (1021) -3 and compound (1021) -4 was obtained by adding 1.1 mg (0.01 mmol) and reacting at room temperature for another 23 hours.
The NMR data of the obtained compounds (1021) -3 and compound (1021) -4 are shown below.
・化合物(1021)-3
 H-NMR(THF-d):0.16ppm.
 13C-NMR(THF-d):1.4ppm.
 29Si-NMR(THF-d):12.5ppm、-109.0ppm.
・化合物(1021)-4
 H-NMR(THF-d):0.16ppm、0.17ppm.
 13C-NMR(THF-d):1.4ppm、1.4ppm、1.4ppm.
 29Si-NMR(THF-d):12.3ppm、12.4ppm、12.4ppm、-100.8ppm、-108.7ppm、-108.8ppm、-108.9ppm.
-Compound (1021) -3
1 1 H-NMR (THF-d 8 ): 0.16 ppm.
13 C-NMR (THF-d 8 ): 1.4 ppm.
29 Si-NMR (THF-d 8 ): 12.5 ppm, -109.0 ppm.
Compound (1021) -4
1 1 H-NMR (THF-d 8 ): 0.16 ppm, 0.17 ppm.
13 C-NMR (THF-d 8 ): 1.4 ppm, 1.4 ppm, 1.4 ppm.
29 Si-NMR (THF-d 8 ): 12.3 ppm, 12.4 ppm, 12.4 ppm, -100.8 ppm, -108.7 ppm, -108.8 ppm, -108.9 ppm.
Figure JPOXMLDOC01-appb-C000059
Figure JPOXMLDOC01-appb-C000059
 [実施例4]
 化合物(2)として、DMAcを含む混合結晶である化合物(22)-3を用い、化合物(1)として化合物(1021)-5を製造した。より具体的には、以下のとおりである。
 化合物(22)-3(1.55g、1.00mmol)をTHF(30ml)に溶解させ、得られた溶液に、アニリン(724mg、9.90mmol)とn-ブチルクロロジメチルシラン(1.49g、9.90mmol)を加えて、室温で3時間撹拌することで、懸濁溶液を得た。この懸濁溶液の各種NMRスペクトルから、未反応の-SiOH部位の存在を確認したため、さらにアニリン(439mg、6.00mmol)とn-ブチルクロロジメチルシラン(904mg、6.00mmol)を加えて、室温で16時間撹拌することで、懸濁溶液を得た。この懸濁溶液の各種NMRスペクトルから、反応が完結し、化合物(1021)-5(「Si12[OSiMe Bu]」)が生成していることを確認した。
 この懸濁溶液にヘキサン(40ml)を加えて塩をろ別した。
 得られたろ液から溶媒を減圧留去することで,無色透明の油状物を得た。この油状物を2等分し、それぞれをヘキサン(21ml)に溶解させ、ヘキサン(250ml)を展開溶媒として、シリカゲルカラムクロマトグラフィーを行った。50mlから200mlの流出分を分取した後、この分取物からヘキサンを減圧留去することで、化合物(1021)-5を無色透明の油状物として得た(収量1.22g、収率83%)。
 得られた化合物(1021)-5のNMRデータを以下に示す。
[Example 4]
Compound (22) -3, which is a mixed crystal containing DMAc, was used as compound (2), and compound (1021) -5 was produced as compound (1). More specifically, it is as follows.
Compound (22) -3 (1.55 g, 1.00 mmol) was dissolved in THF (30 ml), and aniline (724 mg, 9.90 mmol) and n-butylchlorodimethylsilane (1.49 g, 9.90 mmol) was added and the mixture was stirred at room temperature for 3 hours to obtain a suspended solution. Since the presence of unreacted -SiOH moiety was confirmed from various NMR spectra of this suspension solution, aniline (439 mg, 6.00 mmol) and n-butylchlorodimethylsilane (904 mg, 6.00 mmol) were further added to room temperature. The suspension solution was obtained by stirring with the mixture for 16 hours. From the various NMR spectra of this suspension solution, it was confirmed that the reaction was completed and compound (1021) -5 (“Si 8 O 12 [OSiMe 2 n Bu] 8”) was produced.
Hexane (40 ml) was added to this suspension solution and the salt was filtered off.
A colorless and transparent oil was obtained by distilling off the solvent from the obtained filtrate under reduced pressure. The oil was divided into two equal parts, each of which was dissolved in hexane (21 ml), and silica gel column chromatography was performed using hexane (250 ml) as a developing solvent. After fractionating 50 ml to 200 ml of the effluent, hexane was distilled off from this fraction under reduced pressure to obtain compound (1021) -5 as a colorless and transparent oil (yield 1.22 g, yield 83). %).
The NMR data of the obtained compound (1021) -5 is shown below.
 H-NMR(CDCl):0.12ppm、0.59ppm、0.88ppm、1.33ppm、1.53ppm.
 13C-NMR(CDCl):-0.3ppm、13.8ppm、17.4ppm、25.1ppm、26.3ppm.
 29Si-NMR(CDCl):12.6ppm、-108.9ppm.
1 1 H-NMR (CDCl 3 ): 0.12 ppm, 0.59 ppm, 0.88 ppm, 1.33 ppm, 1.53 ppm.
13 C-NMR (CDCl 3 ): -0.3 ppm, 13.8 ppm, 17.4 ppm, 25.1 ppm, 26.3 ppm.
29 Si-NMR (CDCl 3 ): 12.6 ppm, −108.9 ppm.
Figure JPOXMLDOC01-appb-C000060
Figure JPOXMLDOC01-appb-C000060
 本発明は、機能性ケイ素材料又はその中間体として、さらに、これらの製造方法として、利用可能である。 The present invention can be used as a functional silicon material or an intermediate thereof, and further as a method for producing these.

Claims (5)

  1.  下記一般式(2):
    Figure JPOXMLDOC01-appb-C000001
     (式中、pは0、1又は2である。)
    で表される化合物と、下記一般式(3):
    Figure JPOXMLDOC01-appb-C000002
     (式中、R、R及びRは、それぞれ独立に、水素原子、又は置換基を有していてもよいアルキル基若しくはアリール基であり、R、R及びRのうちの2個以上が前記アルキル基又はアリール基である場合、これら基は相互に結合して環を形成していてもよく;Xはハロゲン原子である。)
    で表される化合物と、を反応させることにより、下記一般式(1):
    Figure JPOXMLDOC01-appb-C000003
     (式中、Zは、水素原子又は一般式「-SiR」で表される基であり、(2p+6)個のZは互いに同一でも異なっていてもよく、ただし、1個又は2個以上のZは、前記一般式「-SiR」で表される基であり;p、R、R及びRは、上記と同じである。)
    で表される化合物を得る、化合物の製造方法。
    The following general formula (2):
    Figure JPOXMLDOC01-appb-C000001
    (In the formula, p 1 is 0, 1 or 2.)
    The compound represented by and the following general formula (3):
    Figure JPOXMLDOC01-appb-C000002
    (In the formula, R 1 , R 2 and R 3 are alkyl groups or aryl groups which may independently have a hydrogen atom or a substituent, respectively, and are among R 1 , R 2 and R 3. When two or more are the alkyl or aryl groups, these groups may be bonded to each other to form a ring; X is a halogen atom.)
    By reacting with the compound represented by, the following general formula (1):
    Figure JPOXMLDOC01-appb-C000003
    (Wherein, Z 1 is a group represented by hydrogen atom or formula "-SiR 1 R 2 R 3" may be the same or different from each other (2p 1 +6) number of Z 1, provided that , one or more Z 1, the general formula is a group represented by "-SiR 1 R 2 R 3"; p 1, R 1, R 2 and R 3 are the same as above .)
    A method for producing a compound, which comprises obtaining the compound represented by.
  2.  下記一般式(10):
    Figure JPOXMLDOC01-appb-C000004
     (式中、pは0、1又は2であり;Z10は、水素原子又は一般式「-SiR102030」で表される基であり、(2p+6)個のZ10は互いに同一でも異なっていてもよく、ただし、1個又は2個以上のZ10は、前記一般式「-SiR102030」で表される基であり;R10、R20及びR30は、それぞれ独立に、水素原子、又は置換基を有していてもよいアルキル基若しくはアリール基であり、R10、R20及びR30のうちの2個以上が前記アルキル基又はアリール基である場合、これら基は相互に結合して環を形成していてもよい。)
    で表される化合物(ただし、pが1であり、8個のZ10がすべて式「-Si(CH」、式「-Si(CHH」、式「-Si((4-CH)C)(CH」、式「-Si((4-CBr)C)(CH」、式「-Si((4-COOH)C)(CH」、式「-Si(CH(OSi(CH)」、式「-Si(CH(CH=CH)」、式「-Si(CH=CH」、式「-Si(CHCHCl」、又は式「-Si(CH(OSi(CH)」で表される基である化合物と、pが1であり、7個のZ10が式「-Si(CH」で表される基であり、1個のZ10が水素原子である化合物と、pが1であり、6個のZ10が式「-Si(CH」で表される基であり、2個のZ10が水素原子である化合物と、pが1であり、5個のZ10が式「-Si(CH」で表される基であり、3個のZ10が水素原子である化合物と、を除く)。
    The following general formula (10):
    Figure JPOXMLDOC01-appb-C000004
    (In the formula, p 1 is 0, 1 or 2; Z 10 is a hydrogen atom or a group represented by the general formula "-SiR 10 R 20 R 30 ", and (2p 1 + 6) Z 10s. May be the same or different from each other, except that one or more Z 10s are groups represented by the general formula "-SiR 10 R 20 R 30 "; R 10 , R 20 and R. Reference numeral 30 denotes an alkyl group or an aryl group which may independently have a hydrogen atom or a substituent, and two or more of R 10 , R 20 and R 30 are the alkyl group or the aryl group. In some cases, these groups may be bonded to each other to form a ring.)
    Compounds represented by (where p 1 is 1 and all eight Z 10s are of the formula "-Si (CH 3 ) 3 ", of the formula "-Si (CH 3 ) 2 H", of the formula "-Si ( (4-CH 3 ) C 6 H 4 ) (CH 3 ) 2 ", formula" -Si ((4-CBr 3 ) C 6 H 4 ) (CH 3 ) 2 ", formula" -Si ((4-COOH) ) C 6 H 4 ) (CH 3 ) 2 ”, formula“ -Si (CH 3 ) 2 (OSi (CH 3 ) 3 ) ”, formula“ -Si (CH 3 ) 2 (CH = CH 2 ) ”, formula A group represented by "-Si (CH = CH 2 ) 3 ", the formula "-Si (CH 3 ) 2 CH 2 Cl", or the formula "-Si (CH 3 ) 2 (OSi (CH 3 ) 3 )". A compound in which p 1 is 1, seven Z 10s are groups represented by the formula "-Si (CH 3 ) 3 ", and one Z 10 is a hydrogen atom, and p. 1 is 1, 6 Z 10s are groups represented by the formula "-Si (CH 3 ) 3 ", 2 Z 10s are hydrogen atoms, and p 1 is 1. (Excluding compounds in which 5 Z 10s are groups represented by the formula "-Si (CH 3 ) 3 " and 3 Z 10s are hydrogen atoms).
  3.  前記R10、R20及びR30が、それぞれ独立に、水素原子、炭素数1~20のアルキル基又は炭素数6~20のアリール基である、請求項2に記載の化合物。 The compound according to claim 2 , wherein R 10 , R 20 and R 30 are each independently a hydrogen atom, an alkyl group having 1 to 20 carbon atoms or an aryl group having 6 to 20 carbon atoms.
  4.  前記R10、R20及びR30が、それぞれ独立に、水素原子、炭素数1~6のアルキル基又は炭素数6~12のアリール基である、請求項2又は3に記載の化合物。 The compound according to claim 2 or 3, wherein R 10 , R 20 and R 30 are independently hydrogen atoms, alkyl groups having 1 to 6 carbon atoms or aryl groups having 6 to 12 carbon atoms.
  5.  下記一般式(1021):
    Figure JPOXMLDOC01-appb-C000005
     (式中、Z11は、水素原子又は一般式「-SiR112131」で表される基であり、8個のZ11は互いに同一でも異なっていてもよく、ただし、1個又は2個以上のZ11は、前記一般式「-SiR112131」で表される基であり;R11、R21及びR31は、それぞれ独立に、水素原子、炭素数1~6のアルキル基又は炭素数6~12のアリール基であり、R11、R21及びR31のうちの2個以上が前記アルキル基又はアリール基である場合、これら基は相互に結合して環を形成していてもよい。)
    で表される化合物(ただし、8個のZ11がすべて式「-Si(CH」、式「-Si(CHH」、式「-Si((4-CH)C)(CH」、式「-Si((4-CBr)C)(CH」、式「-Si((4-COOH)C)(CH」、式「-Si(CH(OSi(CH)」、式「-Si(CH(CH=CH)」、式「-Si(CH=CH」、式「-Si(CHCHCl」、又は式「-Si(CH(OSi(CH)」で表される基である化合物と、7個のZ11が式「-Si(CH」で表される基であり、1個のZ11が水素原子である化合物と、6個のZ11が式「-Si(CH」で表される基であり、2個のZ11が水素原子である化合物と、5個のZ11が式「-Si(CH」で表される基であり、3個のZ11が水素原子である化合物と、を除く)。
    The following general formula (1021):
    Figure JPOXMLDOC01-appb-C000005
    (In the formula, Z 11 is a hydrogen atom or a group represented by the general formula "-SiR 11 R 21 R 31 ", and eight Z 11s may be the same or different from each other, but one or one. the two or more Z 11, formula "-SiR 11 R 21 R 31" in be a group represented by; R 11, R 21 and R 31 are independently a hydrogen atom, 6 When two or more of R 11 , R 21 and R 31 are the alkyl groups or aryl groups of the above alkyl groups or aryl groups having 6 to 12 carbon atoms, these groups are bonded to each other to form a ring. It may be formed.)
    Compound represented by (where eight Z 11 are all expressions "-Si (CH 3) 3", the formula "-Si (CH 3) 2 H", the formula "-Si ((4-CH 3) C 6 H 4 ) (CH 3 ) 2 ”, formula“ -Si ((4-CBr 3 ) C 6 H 4 ) (CH 3 ) 2 ”, formula“ -Si ((4-COOH) C 6 H 4 ) ( CH 3 ) 2 ”, formula“ -Si (CH 3 ) 2 (OSi (CH 3 ) 3 ) ”, formula“ -Si (CH 3 ) 2 (CH = CH 2 ) ”, formula“ -Si (CH = CH) 2 ) 3 ", the compound which is the group represented by the formula" -Si (CH 3 ) 2 CH 2 Cl ", or the formula" -Si (CH 3 ) 2 (OSi (CH 3 ) 3) ", and 7 pieces. the Z 11 is a group represented by the formula "-Si (CH 3) 3", and one of Z 11 is a hydrogen atom compound, 6 Z 11 is the formula "-Si (CH 3) 3 a group represented by "and two Z 11 compound is a hydrogen atom, a group five Z 11 represented by the formula" -Si (CH 3) 3 ', 3 Z Except for compounds in which 11 is a hydrogen atom).
PCT/JP2020/040648 2019-10-31 2020-10-29 Compound and production method therefor WO2021085535A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021553684A JPWO2021085535A1 (en) 2019-10-31 2020-10-29

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019-199348 2019-10-31
JP2019199348 2019-10-31

Publications (1)

Publication Number Publication Date
WO2021085535A1 true WO2021085535A1 (en) 2021-05-06

Family

ID=75716345

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2020/040648 WO2021085535A1 (en) 2019-10-31 2020-10-29 Compound and production method therefor

Country Status (2)

Country Link
JP (1) JPWO2021085535A1 (en)
WO (1) WO2021085535A1 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0267290A (en) * 1988-06-29 1990-03-07 Akad Wissenschaften Ddr Oleophilic bicyclic silicic acid derivative having birdcage-shaped structure and its production and use
JP2006104325A (en) * 2004-10-05 2006-04-20 Shin Etsu Chem Co Ltd Monofunctional monomer having cage-like oligosiloxane structure and method for producing the same
WO2008098189A1 (en) * 2007-02-08 2008-08-14 Fujifilm Electronic Materials U.S.A., Inc. Photosensitive compositions employing silicon-containing additives

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0267290A (en) * 1988-06-29 1990-03-07 Akad Wissenschaften Ddr Oleophilic bicyclic silicic acid derivative having birdcage-shaped structure and its production and use
JP2006104325A (en) * 2004-10-05 2006-04-20 Shin Etsu Chem Co Ltd Monofunctional monomer having cage-like oligosiloxane structure and method for producing the same
WO2008098189A1 (en) * 2007-02-08 2008-08-14 Fujifilm Electronic Materials U.S.A., Inc. Photosensitive compositions employing silicon-containing additives

Non-Patent Citations (9)

* Cited by examiner, † Cited by third party
Title
HASEGAWA,I. ET AL.: "Synthesis of silylated derivatives of the cubic octameric silicate species Si80208", SYNTHESIS AND REACTIVITY IN INORGANIC AND METAL-ORGANIC CHEMISTR Y, vol. 24, no. 7, 1994, pages 1099 - 1110 *
HOEBBEL, D. ET AL.: "Preparation and constitution of the crystalline silicic acid trimethylsilyl ester [( CH 3)3Si]6Si6015", ZEITSCHRIFT FUER ANORGANISCHE UND ALLGEMEINE CHEMIE, vol. 552, 1987, pages 236 - 240 *
HUANG,J ET AL.: "Platinum Nanoparticles from the Hydrosilylation Reaction: Capping Agents, Physical Characterizations, and Electrochemical Properties", LANGMUIR, vol. 21, no. 2, 2005, pages 699 - 704, XP055191258, DOI: 10.1021/la0482148 *
KAWAHARA,K. ET AL.: "A spherosilicate oligomer with eight stable silanol groups as a building", NEW JOURNAL OF CHEMISTRY, vol. 36, no. 5, 2012, pages 1210 - 1217 *
NIEMCZYK ARKADIUSZ, ADAMCZYK‐TOMIAK KATARZYNA, DZIUBEK KATARZYNA, CZAJA KRYSTYNA, RABIEJ STANISŁAW, SZATANIK ROMAN, DUTKIEWICZ MIC: "Study of polyethylene nanocomposites with polyhedral oligomeric silsesquioxane nanofillers—from structural characteristics to mechanical properties and processability", POLYMER COMPOSITES, SOCIETY OF PLASTICS ENGINEERS, INC., US, vol. 40, no. S1, 1 January 2019 (2019-01-01), US , pages E350, XP055931336, ISSN: 0272-8397, DOI: 10.1002/pc.24678 *
NOZAWA,T. ET AL.: "Si8012][OH]8: Isolation, and Reactivity of a Cubic Octamer of Orthosilicic Acid", CHEMISTRY LETTERS, vol. 47, no. 12, 2018, pages 1530 - 1533 *
PERRIN FRANCOIS XAVIER, PANAITESCU DENIS MIHAELA, FRONE ADRIANA NICOLETA, RADOVICI CONSTANTIN, NICOLAE CRISTIAN: "The influence of alkyl substituents of POSS in polyethylene nanocomposites", POLYMER, ELSEVIER, AMSTERDAM, NL, vol. 54, no. 9, 1 April 2013 (2013-04-01), AMSTERDAM, NL, pages 2347 - 2354, XP055931331, ISSN: 0032-3861, DOI: 10.1016/j.polymer.2013.02.035 *
S AITO,S. ET AL.: "Cubic Siloxanes with Both Si-H and Si-OtBu Groups for Site- Selective Siloxane Bond Formation", CHEMISTRY - A EUROPEAN JOURNAL, vol. 22, no. 39, 2016, pages 13857 - 13864 *
SMET,S. ET AL.: "Double-four-ring [Si8012][OH]8 cyclosilicate and functionalized spherosilicate synthesis from [N(n-C4H9)4]H7[Si8020] · 5.33H20 cyclosilicate hydrate crystals", CHEMISTRY OF MATERIALS, vol. 29, no. 12, 2017, pages 5063 - 5069, XP055613403, DOI: 10.1021/acs.chemmater.6b04717 *

Also Published As

Publication number Publication date
JPWO2021085535A1 (en) 2021-05-06

Similar Documents

Publication Publication Date Title
US9181283B2 (en) Methods of preparing low molecular weight carbosilanes and precursors thereof
JP2003261580A (en) Method for producing sulfide chain-containing organosilicon compound
JP5115729B2 (en) Organosilicon compound containing acetoacetate group protected with trialkylsilyl group and process for producing the same
EP3186262A1 (en) Fluorosilicon nitrile compounds
JP2009263316A (en) Method for producing incompletely condensed oligosilsesquioxane
WO2021085535A1 (en) Compound and production method therefor
WO2021085482A1 (en) Compound and method for producing same
JP2004352695A (en) Chlorosilane bearing bissilylamino group, method for producing the same and method for producing organooxysilane bearing bissilylamino group
JP2003040895A (en) Method for manufacturing sulfide chain-containing organosilicon compound
JP7360697B2 (en) Compound and its manufacturing method
JPH05306290A (en) Production of @(3754/24)meth)acrylic functional group-containing organosilicon compound
JP2911561B2 (en) N, N&#39;-disubstituted or N, N, N &#39;-/ N, N&#39;, N&#39;-trisubstituted thioureas and their production
JP2022172690A (en) Compound and production method thereof
JPH03263431A (en) Silicon-containing dendrimer
JPH01279912A (en) Organosilicon compound
US9073952B1 (en) Synthesis method for carbosilanes
EP1437357B1 (en) Process for production of alkoxysilane-based compound
CN110741008B (en) Process for preparing silyl bis (acyl) phosphinates
JP7350253B2 (en) Bishaloalkylsiloxane compound and method for producing the same, and method for producing a siloxane compound having both terminal functionalities
JP7131109B2 (en) Method for producing organosilicon compound, method for producing aminoaryl group-containing organosilicon compound, and organosilicon compound
DE102009001758A1 (en) Process for the synthesis of 1,3-bis (aminoalkyl) disiloxanes
JPH0559070A (en) Siloxane compound containing vinyl group and its production
JPS6333384A (en) Production of beta-cyanoalkylsilane
JPH0627197B2 (en) Poly (silivinylene) and method for producing the same
Eliseeva et al. Synthesis and characterization of imidazole–triphenylsilane complexes

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 20881629

Country of ref document: EP

Kind code of ref document: A1

DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)
ENP Entry into the national phase

Ref document number: 2021553684

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 20881629

Country of ref document: EP

Kind code of ref document: A1